Atrophic disorders of skin

L12_ATROPHICSKIN

skin atrophy: The structural changes and the signs and symptoms of chronologically aged skinand those of corticosteroid induced chronicatrophyof theskinare partially very similar.Thinningof epidermis and laxity as well as dryness, purpura and echymoses occur in both conditions.

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 L90
  • Cause of death: ICD-10 L90

2 out of 7 registries used, show all original rules.

5701

4. Check minimum number of events

None

5701

5. Include endpoints

5964

6. Filter based on genotype QC (FinnGen only)

5964

Control definitions (FinnGen only)

Control exclude
L12_OTHERSKINSUBCUTIS

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
L80-L99
Name in latin
Morbositates atrophicae cutis

Similar endpoints

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 35946 27772 8036
Only index persons 34204 26630 7574
Unadjusted period prevalence (%)
Whole population 0.67 0.80 0.22
Only index persons 0.83 0.98 0.29
Median age at first event (years)
Whole population 53.88 58.68 37.42
Only index persons 53.84 58.63 36.98

-FinnGen-

Key figures

All Female Male
Number of individuals 5964 4966 998
Unadjusted period prevalence (%) 1.48 1.69 0.44
Median age at first event (years) 57.88 59.47 49.94

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
5211
Matched controls
52110
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
LFB00
NOMESCO Finland
Biopsy of vulva or perineum
37.3
323.0
1248
436
L90.6
ICD-10 Finland
Striae atrophicae
947.6
323.0
354
*
L90.0
ICD-10 Finland
Lichen sclerosus et atrophicus
458.5
323.0
3346
203
ULA02
NOMESCO Finland
Kolposcopy
7.0
323.0
1514
2861
L90.5
ICD-10 Finland
Scar conditions and fibrosis of skin
1109.6
323.0
1200
14
D07AD01
ATC
clobetasol; topical
10.3
323.0
2577
4536
D07AC01
ATC
betamethasone; topical
2.6
206.9
2241
11822
E0000UV
ATC
NA
2.3
168.2
2483
14846
L91.0
ICD-10 Finland
Hypertrophic scar
49.8
157.8
192
40
D07AB02
ATC
hydrocortisone butyrate; topical
2.3
149.9
1844
9939
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
2.9
145.7
1031
4066
N90.4
ICD-10 Finland
Leukoplakia of vulva
41.6
137.4
173
43
QAE20
NOMESCO Finland
Excision and repair of scar or web of skin of head or neck
37.7
125.3
161
44
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.4
118.4
633
2025
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
2.0
101.2
1831
11187
7092A
ICD-9 Finland
Other disorders of skin and subcutaneous tissue, Scar conditions and fibrosis of skin
+∞
100.3
96
*
70907
ICD-8 Finland
Other diseases of skin, Cicatrix NUD
+∞
98.2
94
*
QBE20
NOMESCO Finland
Excision and repair of scar or web of skin of trunk
15.2
95.7
162
110
J02AC01
ATC
fluconazole; systemic
1.8
95.6
2519
17517
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
2.1
91.9
1348
7513
L90.9
ICD-10 Finland
Atrophic disorder of skin, unspecified
+∞
90.9
87
*
KGH10
NOMESCO Finland
Operation for phimosis
10.3
90.3
183
183
N47
ICD-10 Finland
Redundant prepuce, phimosis and paraphimosis
8.0
77.7
182
234
D07AC13
ATC
mometasone; topical
1.8
75.2
1577
9910
L29.2
ICD-10 Finland
Pruritus vulvae
6.9
75.0
195
293
E000006
ATC
NA
2.8
73.4
514
1952
N76.3
ICD-10 Finland
Subacute and chronic vulvitis
9.8
64.7
134
140
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.0
61.3
965
5403
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.6
61.2
2936
23079
QBE30
NOMESCO Finland
Excision and repair of surgical scar in trunk
11.2
59.6
115
105
L94.0
ICD-10 Finland
Localized scleroderma [morphea]
68.8
59.3
68
10
ZZF00
NOMESCO Finland
Graft of adipose tissue
8.0
57.3
133
169
N76.6
ICD-10 Finland
Ulceration of vulva
9.9
56.9
117
121
LEB00
NOMESCO Finland
Biopsy of vagina
4.7
54.0
192
422
N90.9
ICD-10 Finland
Noninflammatory disorder of vulva and perineum, unspecified
11.0
52.7
102
94
LFC00
NOMESCO Finland
Partial excision of vulva
20.5
52.7
79
39
ZXE00
NOMESCO Finland
One hour or less
1.6
52.4
2033
14899
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
51.7
1864
13395
J01DB01
ATC
cefalexin; oral
1.7
49.2
4136
36389
L43.9
ICD-10 Finland
Lichen planus, unspecified
4.7
48.7
171
371
L90.8
ICD-10 Finland
Other atrophic disorders of skin
482.3
48.4
48
*
E000001
ATC
NA
1.8
48.2
1091
6847
N90.0
ICD-10 Finland
Mild vulvar dysplasia
15.7
47.9
79
51
N48.1
ICD-10 Finland
Balanoposthitis
7.9
47.5
111
143
LFB10
NOMESCO Finland
Excision of lesion of vulva or perineum
7.1
47.2
119
172
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.0
47.1
641
3361
QBJ00
NOMESCO Finland
Liposuction in trunk
10.7
46.5
91
86
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
45.7
1942
14409
N90.8
ICD-10 Finland
Other specified noninflammatory disorders of vulva and perineum
7.0
43.5
110
160
WX408
NOMESCO Finland
General anesthesy, balanced
1.6
43.4
1316
8942
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.1
43.2
557
2851
QBJ30
NOMESCO Finland
Correction of abdominal apron
7.7
43.2
102
134
WX110
NOMESCO Finland
Local anesthesy
1.5
43.2
3430
29133
UJF32
NOMESCO Finland
Coloscopy
1.6
42.4
1262
8524
Z2221
NOMESCO Finland
Medical doctor
1.6
41.5
1411
9858
N02BE01
ATC
paracetamol; systemic, rectal
1.7
41.4
4403
39868
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
40.6
1396
9769
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
40.4
1791
13315
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.4
40.2
360
1556
N90.2
ICD-10 Finland
Severe vulvar dysplasia, not elsewhere classified
18.7
39.6
61
33
L43.8
ICD-10 Finland
Other lichen planus
4.1
39.0
158
395
QDE20
NOMESCO Finland
Excision and repair of scar or web of skin of lower limb
26.0
38.9
54
21
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
38.3
1097
7302
QAE30
NOMESCO Finland
Excision and repair of surgical scar in head or neck
27.6
38.1
52
19
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.8
38.0
703
4102
X16
ICPC
Vulval symptom/complaint
4.9
38.0
127
262
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
7.2
37.7
93
131
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.0
37.2
523
2765
UKC02
NOMESCO Finland
Cystoscopy
1.9
36.8
612
3445
L90.4
ICD-10 Finland
Acrodermatitis chronica atrophicans
130.9
36.7
39
*
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
13.5
36.6
64
48
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
36.5
1264
8815
D07AB01
ATC
clobetasone; topical
2.9
36.4
226
789
A02BC02
ATC
pantoprazole; systemic
1.5
36.2
3196
27182
S18
ICPC
Laceration/cut
1.5
35.1
1949
15076
QCE20
NOMESCO Finland
Excision and repair of scar or web of skin of upper limb
21.4
34.8
51
24
P01AB01
ATC
metronidazole; oral, rectal
1.5
34.5
2039
15961
N02AX02
ATC
tramadol; systemic, rectal
1.5
33.5
1924
14949
M79.6
ICD-10 Finland
Pain in limb
1.5
33.4
1770
13524
7010B
ICD-9 Finland
Other hypertrophic and atrophic conditions of skin, Circumscribed scleroderma[LICHEN SCLEROSUS ET ATROPHICUS]
+∞
33.4
32
*
G04BD12
ATC
mirabegron; oral
1.9
33.1
502
2723
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
32.7
3452
30061
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.9
32.3
207
737
LCA06
NOMESCO Finland
Biopsy of endometrium
1.7
32.0
725
4497
ZZA00
NOMESCO Finland
Split skin graft
3.6
31.8
146
409
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
9.8
31.5
64
66
L90
ICD-10 Finland
Atrophic disorders of skin
53.2
31.3
37
7
A02BC03
ATC
lansoprazole; oral
1.5
30.7
1403
10352
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
30.2
2191
17687
Z3231
NOMESCO Finland
Registered nurse
1.5
30.0
1247
9008
D07AB08
ATC
desonide; topical
1.9
29.9
507
2861
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
29.8
1596
12150
J01MA02
ATC
ciprofloxacin; systemic
1.4
29.4
1714
13261
J02AC02
ATC
itraconazole; systemic
1.6
29.3
925
6256
A02BC05
ATC
esomeprazole; systemic
1.4
29.0
1982
15791
J01FF01
ATC
clindamycin; systemic
1.5
28.9
1225
8871
R03AC02
ATC
salbutamol; inhalant
1.4
28.7
2560
21365
C51.01
ICD-10 Finland
Squamous cell carcinoma of the labium majus
19.2
27.8
42
22
WX320
NOMESCO Finland
Spinalanesthesy
1.5
27.5
1051
7428
TQW99
NOMESCO Finland
Other minor procedure on skin
2.5
27.5
227
939
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
2.4
26.9
233
989
D05BB02
ATC
acitretin; oral
3.4
26.7
134
404
XQ848
NOMESCO Finland
Dermatological photography
3.4
26.5
130
385
N62
ICD-10 Finland
Hypertrophy of breast
2.3
26.3
246
1085
N39.3
ICD-10 Finland
Stress incontinence
1.8
26.3
457
2599
N03AX16
ATC
pregabalin; oral
1.5
26.2
1113
8039
N02AJ06
ATC
codeine and paracetamol; systemic
1.4
26.1
1729
13617
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
25.9
2614
22113
J01EA01
ATC
trimethoprim; systemic
1.4
25.7
1352
10195
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.6
25.6
662
4241
H03AA01
ATC
levothyroxine sodium; systemic
1.4
25.4
1289
9645
HAD99
NOMESCO Finland
Other plastic operation on breast
6.2
25.3
69
113
N90.1
ICD-10 Finland
Moderate vulvar dysplasia
17.8
25.2
39
22
M54.5
ICD-10 Finland
Low back pain
1.4
25.1
1550
12032
WX002
NOMESCO Finland
Sedation and analgesia
1.5
25.1
922
6444
R06AE07
ATC
cetirizine; oral
1.4
25.0
2179
17953
S29
ICPC
Skin symptom/complaint other
1.6
24.6
786
5309
H02AB06
ATC
prednisolone; systemic
1.4
24.6
2145
17653
Z3226
NOMESCO Finland
Physiotherapist
1.5
24.4
861
5954
R05
ICD-10 Finland
Cough
1.5
24.4
932
6567
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
23.5
1057
7701
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
23.2
1363
10454
G01AA10
ATC
clindamycin; vaginal
1.5
23.2
854
5956
M01AE01
ATC
ibuprofen; systemic, rectal
1.5
23.1
4494
42050
KGB00
NOMESCO Finland
Biopsy of penis
54.2
23.0
27
5
9734
FHL
Excision and local plastic or associated free skin grafting
6.6
22.9
59
90
SPAT1153
SPAT
Removal of sutures
1.4
22.7
1452
11298
8070/3-C51.9
ICD-O-3
Squamous cell carcinoma, NOS, of vulva, NOS
16.5
22.7
36
22
J01DA01
ATC
[U] cefalexin; systemic
1.3
22.5
2984
26085
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.4
22.4
1309
10020
R06AX27
ATC
desloratadine; oral
1.4
22.4
1296
9905
M01AE03
ATC
ketoprofen; systemic, rectal
1.4
22.2
1714
13760
D07AA02
ATC
hydrocortisone; topical
1.6
22.2
621
4053
C51.11
ICD-10 Finland
Squamous cell carcinoma of the labium minus
24.0
22.1
31
13
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.9
22.1
342
1863
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
22.0
1889
15425
XKD00
NOMESCO Finland
Uroflowmetry
1.8
21.7
374
2117
N77.8*L43.9
ICD-10 Finland
Vulvovaginal ulceration and inflammation caused by lichen ruber planus
14.5
21.6
36
25
D07BC01
ATC
betamethasone and antiseptics; topical
1.6
21.5
539
3416
Z01.2
ICD-10 Finland
Dental examination
1.3
21.4
1952
16068
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.6
21.2
560
3602
ZXA00
NOMESCO Finland
Right side
1.4
21.1
1236
9442
L93.0
ICD-10 Finland
Discoid lupus erythematosus
50.2
21.1
25
5
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
21.0
3079
27169
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
20.9
2251
18976
WX402
NOMESCO Finland
General anaesthesia
1.5
20.8
739
5105
ZXA10
NOMESCO Finland
Bilateral
1.5
20.8
866
6190
H04.10
ICD-10 Finland
Dry eye syndrome
1.7
20.7
493
3079
R01AD09
ATC
mometasone; nasal
1.3
20.5
2171
18242
ZXE20
NOMESCO Finland
More than three and less than five hours
1.6
20.5
565
3668
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.7
20.3
435
2636
L82
ICD-10 Finland
Seborrhoeic keratosis
1.6
20.1
620
4145
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.5
19.8
653
4434
N06AX16
ATC
venlafaxine; oral
1.5
19.7
646
4378
J01AA02
ATC
doxycycline; systemic
1.3
19.6
3781
34554
D07.1
ICD-10 Finland
Carcinoma in situ: Vulva
29.0
19.6
26
9
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
1.8
19.5
345
1971
C05AA08
ATC
fluocortolone; rectal, topical
1.5
19.4
639
4333
N06AB04
ATC
citalopram; systemic
1.4
19.4
1011
7545
ZZR00
NOMESCO Finland
Flap of skin
3.1
19.4
111
369
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
19.4
719
5011
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
19.4
964
7132
L80
ICD-10 Finland
Vitiligo
14.6
19.3
32
22
LFB20
NOMESCO Finland
Destruction of lesion of vulva or perineum
5.9
19.3
54
93
N30.0
ICD-10 Finland
Acute cystitis
1.5
19.2
697
4832
TQW80
NOMESCO Finland
Local dermatologic skincare
2.9
19.0
117
410
ZXA05
NOMESCO Finland
Left side
1.4
18.9
1127
8615
ZXD20
NOMESCO Finland
Day surgery
1.5
18.8
604
4071
M25.5
ICD-10 Finland
Pain in joint
1.4
18.7
1327
10439
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.6
18.6
542
3566
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.3
18.6
1855
15379
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.3
18.5
167
726
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
18.5
1182
9141
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
18.5
2471
21346
R06.0
ICD-10 Finland
Dyspnoea
1.4
18.5
1078
8203
R4120
NOMESCO Finland
Occupational therapy
1.9
18.4
281
1527
QXA25
NOMESCO Finland
Destruction of lesion of skin, site unspecified
2.9
18.4
111
383
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
18.3
1076
8200
A02BA02
ATC
ranitidine; systemic
1.4
18.2
871
6385
LDA20
NOMESCO Finland
Biopsy of vaginal cervix
1.8
18.2
313
1771
L43
ICD-10 Finland
Lichen planus
3.8
18.1
77
205
R23.8
ICD-10 Finland
Other and unspecified skin changes
1.5
18.1
670
4663
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
1.6
18.0
525
3456
A46
ICD-10 Finland
Erysipelas
1.6
18.0
511
3341
N48.0
ICD-10 Finland
Leukoplakia of penis
33.0
17.9
23
7
G03CA04
ATC
estriol; systemic, vaginal
1.6
17.8
438
2757
8077/2-C51.9
ICD-O-3
Squamous intraepithelial neoplasia, high grade of vulva, NOS
18.1
17.7
27
15
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.4
17.7
1025
7781
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.8
17.6
312
1782
D02AE01
ATC
carbamide; topical
1.8
17.6
308
1749
R21
ICD-10 Finland
Rash and other nonspecific skin eruption
2.1
17.6
204
997
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.4
17.6
935
6992
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.3
17.6
2031
17154
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
17.5
1634
13390
G47.3
ICD-10 Finland
Sleep apnoea
1.4
17.5
782
5658
N48.6
ICD-10 Finland
Induratio penis plastica
15.6
17.4
28
18
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.4
17.4
1258
9908
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
17.4
1743
14423
QDE30
NOMESCO Finland
Excision and repair of surgical scar in lower limb
28.9
17.4
23
8
E66.01
ICD-10 Finland
Obesity due to excess calories
1.7
17.1
355
2130
M03BX02
ATC
tizanidine; oral
1.3
17.1
2944
26177
M01AH05
ATC
etoricoxib; oral
1.3
17.1
2765
24392
K02.1
ICD-10 Finland
Caries of dentine
1.3
17.0
2583
22587
L57.0
ICD-10 Finland
Actinic keratosis
1.7
17.0
364
2204
A02BC01
ATC
omeprazole; systemic
1.4
16.9
1231
9699
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
13.2
16.9
29
22
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
16.9
1973
16664
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
16.8
1389
11167
R4110
NOMESCO Finland
Physiotherapy
1.4
16.6
1177
9230
L17
ICPC
Foot/toe symptom/complaint
1.4
16.6
1135
8851
S21
ICPC
Skin texture symptom/complaint
1.5
16.6
534
3596
J01FA10
ATC
azithromycin; systemic
1.3
16.6
2803
24823
8071/2-C51.9
ICD-O-3
Differentiated intraepithelial neoplasia of vulva, NOS
170.5
16.5
17
*
B01AB05
ATC
enoxaparin; parenteral
1.3
16.5
1340
10737
T90
ICPC
Diabetes non-insulin dependent
1.4
16.5
877
6551
N81.6
ICD-10 Finland
Rectocele
1.7
16.4
390
2433
J01CA04
ATC
amoxicillin; systemic
1.3
16.2
3929
36436
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
3.1
16.2
90
296
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.3
16.2
2636
23195
A63.0
ICD-10 Finland
Anogenital (venereal) warts
2.1
16.2
175
831
G04BD08
ATC
solifenacin; oral
1.8
16.1
309
1808
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
3.7
16.1
71
196
E000002
ATC
NA
1.6
16.1
492
3271
N06AX11
ATC
mirtazapine; oral
1.3
16.0
1451
11802
A98
ICPC
Health maint/preventive medicine
1.7
16.0
4959
48003
N06AX21
ATC
duloxetine; oral
1.5
16.0
503
3367
R53
ICD-10 Finland
Malaise and fatigue
1.4
16.0
886
6660
J05AB01
ATC
aciclovir; systemic
1.4
15.9
979
7493
M01AB05
ATC
diclofenac; systemic, rectal
1.3
15.9
3126
28145
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
15.9
532
3614
UDH02
NOMESCO Finland
Rhinopharyngoscopy
1.8
15.9
282
1612
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
15.8
763
5591
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
2.4
15.8
134
566
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.7
15.7
348
2125
D06BB10
ATC
imiquimod; topical
2.0
15.7
203
1037
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
15.7
3191
28825
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.4
15.7
774
5700
L90.3
ICD-10 Finland
Atrophoderma of Pasini and Pierini
+∞
15.6
15
*
N05BA04
ATC
oxazepam; oral
1.3
15.6
1137
8944
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
15.6
1296
10401
M70.6
ICD-10 Finland
Trochanteric bursitis
1.5
15.6
628
4442
X15
ICPC
Vaginal symptom/complaint other
2.1
15.6
177
859
N35.9
ICD-10 Finland
Urethral stricture, unspecified
6.0
15.5
42
70
A10BA02
ATC
metformin; oral
1.4
15.5
1034
8018
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
15.4
1167
9235
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.4
15.4
1014
7848
R51.80
ICD-10 Finland
Headache
1.5
15.3
658
4711
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.9
15.3
232
1258
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.5
15.3
515
3502
N05CF01
ATC
zopiclone; oral
1.3
15.2
1435
11718
KMAK
NOMESCO Finland
NA
1.3
15.2
2358
20555
N05AH04
ATC
quetiapine; oral
1.4
15.2
672
4845
K13.74
ICD-10 Finland
Lichen rubs planus in the mouth
2.9
15.1
90
312
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.3
15.1
1122
8848
L03
ICPC
Low back symptom/complaint
1.3
15.0
1102
8675
L08
ICPC
Shoulder symptom/complaint
1.4
15.0
834
6269
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
14.9
1803
15223
SPAT1310
SPAT
Counselling related to known health issue
1.3
14.9
1429
11696
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.6
14.9
437
2879
TLW99
NOMESCO Finland
Other minor surgical procedure in gynaecology
2.3
14.8
139
617
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
14.8
738
5437
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.8
14.8
269
1549
G44.2
ICD-10 Finland
Tension-type headache
1.5
14.7
626
4474
SPAT1263
SPAT
Sampling
1.3
14.6
1921
16378
R01AD08
ATC
fluticasone; nasal
1.3
14.6
1292
10450
D07CC01
ATC
betamethasone and antibiotics; topical
1.5
14.5
550
3838
103
Kela drug reimbursment
Diabetes, insulin-treated
1.4
14.5
967
7494
N95.0
ICD-10 Finland
Postmenopausal bleeding
1.5
14.4
472
3189
M01AE02
ATC
naproxen; oral, rectal
1.3
14.4
2651
23535
N76.0
ICD-10 Finland
Acute vaginitis
1.8
14.3
254
1452
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
1.9
14.3
204
1081
TKD00
NOMESCO Finland
Dilatation of urethra
3.9
14.3
58
150
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.5
14.3
442
2947
J45.9
ICD-10 Finland
Asthma, unspecified
1.4
14.3
766
5718
J01MA12
ATC
levofloxacin; systemic
1.4
14.2
714
5270
TPH04
NOMESCO Finland
Cathetrisation of vein
1.4
14.1
818
6183
J01MA06
ATC
norfloxacin; oral
1.4
14.1
642
4644
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
14.1
1976
16964
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.5
14.0
503
3465
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
14.0
688
5052
HA1AA
NOMESCO Finland
X-ray mammography
1.5
13.9
428
2850
R87.6
ICD-10 Finland
Abnormal findings in specimens from female genital organs, abnormal cytological findings
1.5
13.9
454
3064
D02AX
ATC
Other emollients and protectives
2.1
13.9
153
734
HAE99
NOMESCO Finland
Other reconstruction of breast
3.5
13.8
64
185
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
2.5
13.7
109
448
M03BC01
ATC
orphenadrine (citrate); systemic
1.3
13.7
1023
8055
D01AA02
ATC
natamycin; topical
2.6
13.7
101
397
N94.1
ICD-10 Finland
Dyspareunia
3.3
13.7
68
208
N76.1
ICD-10 Finland
Subacute and chronic vaginitis
2.6
13.7
97
372
K03.64
ICD-10 Finland
Dental calculus supragingival
1.3
13.7
1236
10010
Z01.4
ICD-10 Finland
Gynaecological examination (general)(routine)
1.4
13.6
822
6254
Z42.1
ICD-10 Finland
Follow-up care involving plastic surgery of breast
3.9
13.6
55
142
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.7
13.6
265
1560
L98.1
ICD-10 Finland
Factitial dermatitis
+∞
13.5
13
*
L90.1
ICD-10 Finland
Anetoderma of Schweninger-Buzzi
+∞
13.5
13
*
L30.4
ICD-10 Finland
Erythema intertrigo
3.6
13.5
61
173
Z71.8
ICD-10 Finland
Other specified counselling
1.3
13.5
1023
8072
R42
ICD-10 Finland
Dizziness and giddiness
1.3
13.4
953
7443
N03AX12
ATC
gabapentin; oral
1.4
13.4
644
4707
A10BH01
ATC
sitagliptin; oral
1.6
13.4
345
2199
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
2.5
13.3
99
393
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.3
13.2
1143
9190
R05
ICPC
Cough
1.3
13.2
1003
7915
R01AD12
ATC
fluticasone furoate; nasal
1.3
13.2
1332
10941
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
13.2
1232
10018
J05AB11
ATC
valaciclovir; oral
1.4
13.2
586
4221
LFA00
NOMESCO Finland
Incision of vulva or perineum
6.8
13.1
32
47
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.4
13.1
613
4459
SPAT1262
SPAT
Handing over of treatment supplies
1.4
13.0
694
5169
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
1.6
13.0
327
2073
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
12.9
2269
19938
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
1.6
12.8
363
2369
XKD03
NOMESCO Finland
Urethral pressure profilometry
2.2
12.8
126
577
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.5
12.8
398
2657
K59.1
ICD-10 Finland
Functional diarrhoea
1.8
12.7
229
1317
L89
ICD-10 Finland
Decubitus ulcer and pressure area
7.8
12.6
28
36
SPAT1301
SPAT
No procedures
1.3
12.6
1383
11479
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.6
12.5
346
2246
D01
ICPC
Abdominal pain/cramps general
1.5
12.5
475
3314
7018X
ICD-9 Finland
Other hypertrophic and atrophic conditions of skin, Other specified hypertrophic and atrophic conditions of skin[ATROPHIA CUTIS ALIA DEFINITA]
+∞
12.5
12
*
A01AB09
ATC
miconazole; local oral
1.5
12.5
414
2805
R03BA02
ATC
budesonide; inhalant
1.4
12.4
766
5841
L28.0
ICD-10 Finland
Lichen simplex chronicus
3.4
12.4
59
175
LFD10
NOMESCO Finland
Vulvectomy and excision of regional lymph nodes
20.1
12.4
18
9
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.6
12.4
332
2134
S06.0
ICD-10 Finland
Concussion
1.5
12.4
410
2773
ZXD05
NOMESCO Finland
Urgent procedure
1.3
12.4
1260
10345
WZA90
NOMESCO Finland
Other doctors statement
1.3
12.4
995
7908
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
12.4
732
5549
D01AC02
ATC
miconazole; topical
1.7
12.3
282
1742
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.5
12.3
464
3232
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
1.5
12.3
397
2672
M79.1
ICD-10 Finland
Myalgia
1.4
12.2
553
3995
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
2.0
12.2
162
838
L43.0
ICD-10 Finland
Hypertrophic lichen planus
4.2
12.2
45
108
N76.2
ICD-10 Finland
Acute vulvitis
4.2
12.2
45
108
I10
ICD-10 Finland
Essential (primary) hypertension
1.2
12.1
2433
21636
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.6
12.1
338
2198
XKC03
NOMESCO Finland
Water cystometry
2.0
12.1
151
764
J01FA06
ATC
roxithromycin; oral
1.2
12.0
1838
15853
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.3
12.0
1096
8867
G04BD04
ATC
oxybutynin; oral, transdermal
1.7
12.0
253
1528
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.5
11.9
443
3079
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.6
11.9
309
1976
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.4
11.8
518
3717
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.7
11.8
270
1668
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.4
11.8
500
3564
R52.2
ICD-10 Finland
Other chronic pain
2.0
11.8
144
722
G03CC04
ATC
estrone; systemic
1.8
11.8
189
1049
K60.1
ICD-10 Finland
Chronic anal fissure
2.3
11.7
102
441
KDH10
NOMESCO Finland
Meatoplasty of urethra
16.4
11.6
18
11
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.3
11.6
910
7198
R30.0
ICD-10 Finland
Dysuria
2.0
11.6
152
785
D07XC01
ATC
betamethasone, combinations; topical
1.5
11.5
448
3140
104
Kela drug reimbursment
Thyroid insufficiency
1.5
11.5
369
2482
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.6
11.5
307
1977
WX290
NOMESCO Finland
Other blockade of nerve
1.2
11.4
1877
16294
D01AC03
ATC
econazole; topical
1.7
11.4
234
1402
E66.00
ICD-10 Finland
Metabolic syndrome
1.8
11.4
197
1122
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.4
11.3
560
4112
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.5
11.3
423
2941
L01
ICPC
Neck symptom/complaint
1.4
11.3
608
4532
L85.9
ICD-10 Finland
Epidermal thickening, unspecified
35.1
11.3
14
*
L28
ICPC
Limited function/disability (L)
1.4
11.2
620
4640
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.5
11.2
361
2432
R60.0
ICD-10 Finland
Localized oedema
1.5
11.2
431
3013
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
1.6
11.2
278
1758
SBA00
NOMESCO Finland
Microbiological examinations
2.2
11.1
112
520
N90.5
ICD-10 Finland
Atrophy of vulva
7.6
11.1
25
33
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.5
11.1
348
2327
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.6
11.1
263
1642
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.7
11.1
243
1485
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.4
11.0
505
3652
N06AB10
ATC
escitalopram; oral
1.3
11.0
855
6751
H01
ICPC
Ear pain/earache
1.5
11.0
442
3119
SDA02
NOMESCO Finland
Parodonthologic therapy
1.3
11.0
1442
12186
C51.9
ICD-10 Finland
Malignant neoplasm: Vulva, unspecified
11.1
11.0
20
18
R35
ICD-10 Finland
Polyuria
1.7
11.0
208
1219
Z00.8
ICD-10 Finland
Other general examinations
1.6
11.0
279
1774
TLC00
NOMESCO Finland
Insertion of intrauterine device
1.6
10.9
256
1593
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
1.9
10.9
164
890
U02
ICPC
Urinary frequency/urgency
1.4
10.9
620
4663
J01CA08
ATC
pivmecillinam; oral
1.2
10.9
2199
19488
R5140
NOMESCO Finland
Monitoring the use of the aid
1.5
10.8
355
2399
QAA25
NOMESCO Finland
Destruction of lesion of head or neck
2.4
10.8
87
362
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.3
10.8
905
7226
R13
ICD-10 Finland
Dysphagia
1.6
10.8
245
1514
R33
ICD-10 Finland
Retention of urine
1.8
10.8
173
963
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.8
10.7
182
1032
N84.0
ICD-10 Finland
Polyp of corpus uteri
1.5
10.7
385
2656
X58
ICD-10 Finland
Exposure to other specified factors
1.4
10.6
517
3783
QAE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of head or neck
7.5
10.6
24
32
G03CB01
ATC
dienestrol; oral, vaginal
1.9
10.5
155
835
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.3
10.5
796
6259
Z2446
NOMESCO Finland
Social worker
1.6
10.5
250
1562
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.6
10.4
238
1471
ZXE30
NOMESCO Finland
More than five and less than seven hours
1.8
10.4
183
1049
N06AA09
ATC
amitriptyline; systemic
1.4
10.4
446
3187
L70.0
ICD-10 Finland
Acne vulgaris
2.3
10.4
93
409
E66.8
ICD-10 Finland
Other obesity
1.7
10.4
211
1265
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
10.3
703
5438
E000007
ATC
NA
1.6
10.3
237
1467
D11
ICPC
Diarrhoea
1.4
10.3
464
3347
L30.8
ICD-10 Finland
Other specified dermatitis
2.3
10.3
93
411
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
10.3
1795
15635
A07AA02
ATC
nystatin; oral
1.6
10.3
275
1771
WX702
NOMESCO Finland
Supraglottic ventilation device
1.7
10.3
220
1339
ZZS45
NOMESCO Finland
Z-plasty
18.8
10.2
15
8
L98.88
ICD-10 Finland
Other specified disorders of skin and subcutaneous tissue
7.1
10.2
24
34
N05BA01
ATC
diazepam; systemic, rectal
1.4
10.2
557
4158
ZY010
NOMESCO Finland
Hospital outpatient
1.8
10.2
183
1056
QBA99
NOMESCO Finland
Other local destruction of skin of trunk
4.1
10.2
38
93
S76
ICPC
Skin infection other
1.8
10.2
184
1061
WX240
NOMESCO Finland
Penis blockade
13.1
10.1
17
13
R03DC03
ATC
montelukast; oral
1.3
10.1
697
5402
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.0
10.1
129
660
R06AE09
ATC
levocetirizine; oral
1.4
10.1
628
4792
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
1.5
10.0
319
2144
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
2.9
10.0
58
200
U01
ICPC
Dysuria/painful urination
1.5
9.9
360
2489
A03FA02
ATC
cisapride; oral, rectal
1.5
9.9
344
2358
R2110
NOMESCO Finland
Giving the first information
1.5
9.8
305
2037
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
2.0
9.8
114
563
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.3
9.8
1131
9392
T86
ICPC
Hypothyroidism/myxoedema
1.7
9.8
190
1122
UJD02
NOMESCO Finland
Gastroscopy
1.7
9.8
188
1105
N06AB03
ATC
fluoxetine; oral
1.4
9.8
551
4133
R50.9
ICD-10 Finland
Fever, unspecified
1.4
9.8
505
3732
N95.2
ICD-10 Finland
Postmenopausal atrophic vaginitis
1.5
9.8
297
1972
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
3.3
9.8
48
148
SPAT1312
SPAT
General health counselling
1.2
9.8
1387
11798
R21
ICPC
Throat symptom/complaint
1.3
9.8
835
6676
D07AC14
ATC
methylprednisolone aceponate; topical
1.7
9.7
203
1227
B07.9
ICD-10 Finland
Verruca simplex
2.0
9.7
120
609
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.3
9.6
716
5610
N06AG02
ATC
moclobemide; oral
1.7
9.6
184
1082
R06.5
ICD-10 Finland
Mouth breathing
1.5
9.6
299
1998
-1
NOMESCO Finland
NA
1.2
9.6
1416
12094
A01
ICPC
Pain general/multiple sites
1.5
9.6
324
2204
L12
ICPC
Hand/finger symptom/complaint
1.4
9.6
596
4545
8474
FHL
Coagulation, excision, or biopsy of local change (eg, condyloma, tumor) in operating room or anesthesia
4.9
9.6
30
62
QAA40
NOMESCO Finland
Laser therapy or photocoagulation of skin of head or neck
4.9
9.6
30
62
N06AX12
ATC
bupropion; oral
1.6
9.5
231
1454
N03AX09
ATC
lamotrigine; oral
1.7
9.5
180
1053
SPAT1240
SPAT
Therapeutic discussion
1.4
9.5
427
3078
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.4
9.5
447
3250
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.6
9.5
260
1690
A60.0
ICD-10 Finland
Herpesviral infection of genitalia and urogenital tract
2.4
9.4
74
305
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
2.4
9.4
77
324
UJF30
NOMESCO Finland
Ileoscopy through colon
1.4
9.4
381
2694
XQ800
NOMESCO Finland
Prick test
1.5
9.3
309
2097
L13
ICPC
Hip symptom/complaint
1.3
9.3
683
5344
C51.81
ICD-10 Finland
Squamous cell carcinoma of the vulva
10.7
9.3
17
16
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.6
9.2
248
1599
LEF03
NOMESCO Finland
Posterior colporrpahy with sutures for primary rectocele
1.6
9.2
216
1348
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
1.4
9.2
390
2781
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.5
9.2
351
2454
K59.0
ICD-10 Finland
Constipation
1.6
9.2
214
1333
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
1.2
9.2
1587
13772
D06BB03
ATC
aciclovir; topical
1.6
9.2
217
1356
N77.1*B37.3
ICD-10 Finland
Candidiasis of vulva and vagina
2.2
9.2
85
382
AA1AD
NOMESCO Finland
CT of head and brain
1.3
9.1
899
7316
XQ802
NOMESCO Finland
Epicutan test
1.7
9.1
178
1056
S01
ICPC
Pain/tenderness of skin
1.7
9.1
169
986
N81.1
ICD-10 Finland
Cystocele
1.5
9.0
346
2419
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
5.3
9.0
26
49
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.7
9.0
193
1176
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.4
9.0
462
3414
ULC02
NOMESCO Finland
Hysteroscopy
1.6
9.0
255
1669
A01AB04
ATC
amphotericin B; local oral
1.6
9.0
206
1278
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
1.9
9.0
133
721
ZQX00
NOMESCO Finland
0-4% of the skin
10.0
9.0
17
17
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
2.2
9.0
84
379
TQW11
NOMESCO Finland
Vacuum treatment of wound
2.5
9.0
68
274
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.5
8.9
318
2191
LFD00
NOMESCO Finland
Vulvectomy
18.6
8.9
13
7
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.4
8.9
392
2817
H13
ICPC
Plugged feeling ear
1.3
8.9
662
5185
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.7
8.9
169
991
Z00.0
ICD-10 Finland
General medical examination
1.3
8.9
745
5933
N89.5
ICD-10 Finland
Stricture and atresia of vagina
7.4
8.9
20
27
B81
ICPC
Anaemia vit B12/folate deficiency
1.8
8.9
138
761
N06AB06
ATC
sertraline; oral
1.4
8.9
447
3292
M94.0
ICD-10 Finland
Chondrocostal junction syndrome [Tietze]
2.0
8.9
103
511
ZXC12
NOMESCO Finland
Pulse colorlaser
5.7
8.9
24
42
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.2
8.9
1712
15008
N05CF02
ATC
zolpidem; oral
1.3
8.9
773
6191
EKA10
NOMESCO Finland
Biopsy of cheek
2.1
8.9
100
490
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.4
8.8
369
2626
M54.4
ICD-10 Finland
Lumbago with sciatica
1.3
8.8
679
5343
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.4
8.8
419
3055
ZXC50
NOMESCO Finland
Cryotherapy
2.1
8.8
99
483
9733
FHL
Excision of skin change in operating room or anesthesia
2.5
8.8
64
255
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.5
8.8
282
1900
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.4
8.7
399
2885
WZC30
NOMESCO Finland
Teaching
1.4
8.7
506
3816
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.0
8.7
103
512
A02BDXX
ATC
NA
1.8
8.7
151
862
TQW40
NOMESCO Finland
Remowal of suture of skin
1.5
8.7
277
1862
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
1.8
8.7
138
766
R32
ICD-10 Finland
Unspecified urinary incontinence
1.9
8.7
130
706
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.3
8.7
684
5403
D06
ICPC
Abdominal pain localized other
1.4
8.7
347
2446
J01MA01
ATC
ofloxacin; systemic
1.5
8.7
303
2079
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
1.7
8.7
167
988
B37.3
ICD-10 Finland
Candidiasis of vulva and vagina
2.4
8.6
67
276
R52.9
ICD-10 Finland
Pain, unspecified
1.4
8.6
342
2410
QDE35
NOMESCO Finland
Repair of skin defect in lower limb after surgery or injury
5.5
8.6
24
44
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.4
8.6
484
3633
Z11.3
ICD-10 Finland
Special screening examination for infections with a predominantly sexual mode of transmission
1.6
8.6
203
1272
TKC22
NOMESCO Finland
Catheterisation instruction
2.6
8.5
59
229
L85.89
ICD-10 Finland
Other specified epidermal thickening
27.5
8.5
11
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
2.1
8.5
92
442
R03AC03
ATC
terbutaline; inhalant
1.3
8.5
592
4598
L29.0
ICD-10 Finland
Pruritus ani
3.0
8.4
45
149
Y04
ICPC
Penis symptom/complaint other
7.3
8.4
19
26
M02AA07
ATC
piroxicam; topical
1.2
8.4
1634
14315
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.4
8.4
335
2366
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.3
8.4
776
6265
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
1.7
8.3
155
906
H02AB04
ATC
methylprednisolone; systemic
1.3
8.3
585
4544
L90.2
ICD-10 Finland
Anetoderma of Jadassohn-Pellizzari
+∞
8.3
8
*
70906
ICD-8 Finland
Other diseases of skin, Cicatrix atrophica
+∞
8.3
8
*
R06AX22
ATC
ebastine; oral
1.3
8.3
755
6076
G04BD07
ATC
tolterodine; oral
1.6
8.3
210
1338
R15
ICD-10 Finland
Faecal incontinence
1.9
8.3
123
667
A06AC51
ATC
ispaghula, combinations; systemic
1.6
8.3
208
1322
R03BA01
ATC
beclometasone; inhalant
1.3
8.3
574
4448
H29
ICPC
Ear symptom/complaint other
1.4
8.3
394
2873
N48.5
ICD-10 Finland
Ulcer of penis
10.7
8.3
15
14
X01
ICPC
Genital pain female
3.1
8.3
43
140
NGA30
NOMESCO Finland
Exploration of knee joint, arthroscopic
1.6
8.3
200
1262
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.3
8.2
540
4152
SPAT1211
SPAT
Application of soft bandage
1.4
8.2
359
2579
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
3.3
8.2
39
119
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.3
8.2
691
5506
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
1.3
8.2
499
3795
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.4
8.2
460
3451
L29.9
ICD-10 Finland
Pruritus, unspecified
2.0
8.2
95
472
R10.2
ICD-10 Finland
Pelvic and perineal pain
2.1
8.2
90
436
H81.1
ICD-10 Finland
Benign paroxysmal vertigo
1.4
8.2
411
3024
L81.4
ICD-10 Finland
Other melanin hyperpigmentation
5.4
8.1
23
43
TQB05
NOMESCO Finland
Puncture of skin of trunk
2.8
8.1
49
176
Z70.8
ICD-10 Finland
Other sex counselling
4.7
8.1
26
56
L40.0
ICD-10 Finland
Psoriasis vulgaris
1.7
8.1
149
868
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.4
8.1
456
3424
H93.1
ICD-10 Finland
Tinnitus
1.5
8.1
256
1720
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
1.8
8.1
136
771
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.2
8.1
1423
12344
SPAT1260
SPAT
Consultation of another employee
1.3
8.0
739
5959
M01AH01
ATC
celecoxib; oral (coxibs)
1.3
8.0
764
6189
J01FA09
ATC
clarithromycin; systemic
1.2
8.0
1396
12092
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
1.7
8.0
148
864
H02AB07
ATC
prednisone; oral
1.3
8.0
565
4393
G50.1
ICD-10 Finland
Atypical facial pain
2.2
7.9
81
379
R51.81
ICD-10 Finland
Facial pain NOS
2.0
7.9
98
500
Z2445
NOMESCO Finland
Psychologist
1.7
7.9
141
816
C03CA01
ATC
furosemide; systemic
1.2
7.9
981
8196
S15
ICPC
Foreign body in skin
1.5
7.9
230
1517
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.3
7.9
612
4823
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
1.8
7.9
138
792
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
1.6
7.9
176
1085
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.2
7.9
2115
19058
M77.4
ICD-10 Finland
Metatarsalgia
1.5
7.8
228
1503
F60.31
ICD-10 Finland
Emotionally unstable personality disorder, borderline condition
2.5
7.8
58
234
D01BA02
ATC
terbinafine; oral; topical
1.2
7.8
932
7752
D01AE15
ATC
terbinafine; topical
1.5
7.8
234
1556
T82
ICPC
Obesity
1.7
7.8
145
852
A07EC02
ATC
mesalazine; oral, rectal
1.6
7.8
193
1224
D06BB04
ATC
podophyllotoxin; topical
1.6
7.8
180
1120
L05
ICPC
Flank/axilla symptom/complaint
1.6
7.8
201
1290
H53.1
ICD-10 Finland
Subjective visual disturbances
1.5
7.8
248
1669
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.0
7.8
96
489
SFA00
NOMESCO Finland
Small filling
1.3
7.7
516
3978
D22.5
ICD-10 Finland
Melanocytic naevi of trunk
1.6
7.7
191
1209
L16
ICPC
Ankle symptom/complaint
1.4
7.7
403
2985
K30
ICD-10 Finland
Functional dyspepsia
1.4
7.7
432
3240
8070/3-C51.1
ICD-O-3
Squamous cell carcinoma, NOS, of labium minus
45.0
7.7
9
*
A07EA06
ATC
budesonide; oral, local oral
1.8
7.7
133
761
D06BX01
ATC
metronidazole; topical
1.4
7.7
450
3397
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.3
7.7
563
4399
E000003
ATC
NA
1.7
7.7
161
979
M72.2
ICD-10 Finland
Plantar fascial fibromatosis
1.4
7.7
299
2103
QAJ30
NOMESCO Finland
Other facelift
5.5
7.7
21
38
HAD40
NOMESCO Finland
Mastopexy
3.4
7.7
34
99
K60.2
ICD-10 Finland
Anal fissure, unspecified
2.3
7.6
66
288
C07AB07
ATC
bisoprolol; oral
1.2
7.6
1877
16771
EBB15
NOMESCO Finland
Insertion of dental implant abutment
3.3
7.6
36
110
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.4
7.6
429
3220
C10AA07
ATC
rosuvastatin; oral
1.2
7.6
939
7838
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.5
7.6
274
1897
QCE30
NOMESCO Finland
Excision and repair of surgical scar in upper limb
18.4
7.6
11
6
SXC05
NOMESCO Finland
Other oral or dental procedure
1.5
7.6
219
1442
L29.3
ICD-10 Finland
Anogenital pruritus, unspecified
8.0
7.6
16
20
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.4
7.6
443
3347
G01AF01
ATC
metronidazole; vaginal
1.3
7.6
493
3787
G04BD11
ATC
fesoterodine; oral
1.8
7.6
121
677
N63
ICD-10 Finland
Unspecified lump in breast
1.5
7.6
279
1938
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.0
7.5
86
426
N76.8
ICD-10 Finland
Other specified inflammation of vagina and vulva
2.4
7.5
60
253
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.3
7.5
461
3510
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.5
7.5
221
1462
LC2HE
NOMESCO Finland
Hystero-salpingography with ultrasound
1.6
7.5
190
1212
QAE99
NOMESCO Finland
Other excision or repair surgery of skin and subcutaneous tissue in head and neck
2.1
7.5
81
393
R01BA52
ATC
pseudoephedrine, combinations; oral
1.2
7.5
1396
12158
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.3
7.5
734
5964
R03BA05
ATC
fluticasone; inhalant
1.3
7.5
766
6256
N06AX03
ATC
mianserin; oral
1.6
7.5
190
1216
KCV12
NOMESCO Finland
Urinary bladder endoscopic botulin therapy
3.1
7.4
38
123
359
Kela drug reimbursment
Mirabegroni
3.5
7.4
32
91
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
1.2
7.4
963
8078
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
1.6
7.4
205
1335
G01AF05
ATC
econazole; vaginal
1.4
7.4
384
2845
A03FA01
ATC
metoclopramide; systemic, rectal
1.2
7.4
905
7548
A10BK03
ATC
empagliflozin; oral
1.5
7.4
221
1470
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.3
7.3
479
3677
XQ845
NOMESCO Finland
Dermatoscopy
2.8
7.3
44
158
S99
ICPC
Skin disease other
2.2
7.3
72
334
R02
ICPC
Shortness of breath/dyspnoea
1.3
7.3
468
3583
B01AB10
ATC
tinzaparin; parenteral
1.5
7.2
255
1754
S01.2
ICD-10 Finland
Open wound of nose
2.6
7.2
49
190
TDM10
NOMESCO Finland
Puncture of maxillary antrum
1.7
7.2
150
909
D19
ICPC
Teeth/gum symptom/complaint
1.2
7.2
1078
9179
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.3
7.2
551
4331
L91.9
ICD-10 Finland
Hypertrophic disorder of skin, unspecified
15.7
7.2
11
7
QB2S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in chest
3.1
7.2
36
115
T78.4
ICD-10 Finland
Allergy, unspecified
1.6
7.2
176
1114
R07.0
ICD-10 Finland
Pain in throat
1.5
7.2
237
1608
S97
ICPC
Chronic ulcer skin
1.7
7.2
146
878
B03BA03
ATC
hydroxocobalamin; parenteral
1.6
7.2
193
1249
S80.0
ICD-10 Finland
Contusion of knee
1.5
7.2
250
1717
F60.30
ICD-10 Finland
Emotionally unstable personality disorder, impulsive
2.3
7.2
64
286
L98.0
ICD-10 Finland
Pyogenic granuloma
7.3
7.2
16
22
EBB10
NOMESCO Finland
Insertion of dental implant
2.4
7.1
57
241
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
1.9
7.1
97
513
E03.89
ICD-10 Finland
Other specified hypothyroidism
1.6
7.1
155
951
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
1.7
7.1
140
837
D01AE16
ATC
amorolfine; topical
1.3
7.1
452
3462
C01CA24
ATC
epinephrine; parenteral
1.5
7.1
237
1613
A07EA02
ATC
hydrocortisone; rectal
2.0
7.1
84
422
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.4
7.0
285
2017
UDQ12
NOMESCO Finland
Flexible laryngoscopy
1.6
7.0
196
1281
Z42.2
ICD-10 Finland
Follow-up care involving plastic surgery of other parts of trunk
10.0
7.0
13
13
K02.0
ICD-10 Finland
Caries limited to enamel
1.3
7.0
530
4159
SDE02
NOMESCO Finland
Periodontal treatment by dental hygienist
1.2
7.0
1033
8782
ZZR10
NOMESCO Finland
Flap of skin and muscle
2.7
7.0
43
158
Z70.9
ICD-10 Finland
Sex counselling, unspecified
7.0
7.0
16
23
L02
ICPC
Back symptom/complaint
1.4
7.0
363
2689
TLC02
NOMESCO Finland
Simple extraction of IUD
1.6
7.0
162
1011
LCA13
NOMESCO Finland
Curettage of cervix and body of uterus
1.4
7.0
309
2226
L84
ICD-10 Finland
Corns and callosities
1.9
6.9
90
470
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.3
6.9
455
3502
J31.0
ICD-10 Finland
Chronic rhinitis
1.4
6.9
301
2167
C07AA05
ATC
propranolol; systemic
1.2
6.9
825
6862
R07.3
ICD-10 Finland
Other chest pain
1.4
6.9
344
2533
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.3
6.9
537
4234
A04
ICPC
Weakness/tiredness general
1.3
6.9
506
3959
U07
ICPC
Urine symptom/complaint other
1.5
6.8
221
1495
N77.8
ICD-10 Finland
Vulvovaginal ulceration and inflammation in other diseases classified elsewhere
8.3
6.8
14
17
R96
ICPC
Asthma
1.4
6.8
350
2589
R03BA08
ATC
ciclesonide; inhalant
1.4
6.8
330
2418
R01AD01
ATC
beclometasone; nasal
1.3
6.8
636
5136
QAB00
NOMESCO Finland
Suture of skin of head or neck
2.5
6.8
49
197
C51.00
ICD-10 Finland
Malignant tumor of the labium majus without histology
10.9
6.8
12
11
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
4.2
6.8
24
58
HAD20
NOMESCO Finland
Liposuction of breast
5.0
6.8
20
40
L92.0
ICD-10 Finland
Granuloma annulare
9.3
6.8
13
14
R05FA02
ATC
opium derivatives and expectorants; systemic
1.2
6.8
1805
16192
LFE00
NOMESCO Finland
Suture of vulva
40.1
6.8
8
*
SPAT1255
SPAT
Intravenous administration of medicine
1.5
6.7
217
1468
LDA10
NOMESCO Finland
Curettage of cervix uteri
1.6
6.7
174
1117
WX306
NOMESCO Finland
Lumbar epidural anesthesy
1.5
6.7
237
1633
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
2.1
6.7
73
357
LFE10
NOMESCO Finland
Plastic repair of vulva
4.7
6.7
21
45
SBB10
NOMESCO Finland
Teeth copy
1.5
6.7
231
1587
Z01.9
ICD-10 Finland
Special examination, unspecified
1.5
6.7
216
1460
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.3
6.7
519
4090
D10BA01
ATC
isotretinoin; oral
1.5
6.7
222
1513
K03.00
ICD-10 Finland
Approximal wear
1.6
6.7
178
1151
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.4
6.7
369
2763
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
2.2
6.7
65
302
L73.2
ICD-10 Finland
Hidradenitis suppurativa
2.7
6.7
41
151
C08CA01
ATC
amlodipine; oral
1.2
6.7
1336
11689
RF210
NOMESCO Finland
NA
1.8
6.7
109
614
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.4
6.7
321
2349
G04CA02
ATC
tamsulosin; oral
1.4
6.7
302
2187
R01AD11
ATC
triamcinolone; nasal
1.4
6.7
366
2737
G01AF04
ATC
miconazole; vaginal
1.5
6.6
223
1521
P03
ICPC
Feeling depressed
1.4
6.6
342
2533
J01AA07
ATC
tetracycline; systemic
1.3
6.6
612
4932
L15
ICPC
Knee symptom/complaint
1.2
6.6
882
7415
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.6
6.6
149
926
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.5
6.6
208
1400
L21.0
ICD-10 Finland
Seborrhoea capitis
2.8
6.6
40
146
C09DA01
ATC
losartan and diuretics; oral
1.4
6.6
377
2839
N77.1
ICD-10 Finland
Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere
2.5
6.6
50
205
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.3
6.6
510
4014
ZXB10
NOMESCO Finland
Medial
3.4
6.6
29
85
D82
ICPC
Teeth/gum disease
1.2
6.6
1448
12776
M01AC06
ATC
meloxicam; systemic, rectal
1.2
6.6
1637
14593
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.5
6.6
48
195
C10AA05
ATC
atorvastatin; oral
1.2
6.6
1425
12557
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
1.5
6.6
188
1241
R60.9
ICD-10 Finland
Oedema, unspecified
1.6
6.6
177
1151
N06AX18
ATC
reboxetine; oral
2.4
6.6
53
225
LCB25
NOMESCO Finland
Hysteroscopic excision of lesion
1.5
6.5
219
1495
TKC20
NOMESCO Finland
Catheterisation of bladder
1.5
6.5
204
1370
R19.5
ICD-10 Finland
Other faecal abnormalities
2.2
6.5
64
298
F60.3
ICD-10 Finland
Emotionally unstable personality disorder
2.6
6.5
44
171
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.4
6.5
368
2765
TAC99
NOMESCO Finland
Other blockade for chronic pain
3.0
6.5
35
119
M79.0
ICD-10 Finland
Rheumatism, unspecified
1.6
6.5
167
1075
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
1.4
6.5
258
1823
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.4
6.5
337
2501
D07XB05
ATC
dexamethasone, combinations; topical
1.8
6.5
102
571
SPAT1203
SPAT
Injection therapy, other than intramuscular or subcutaneous
1.6
6.5
162
1036
JAH01
NOMESCO Finland
Laparoscopy
1.6
6.5
176
1148
DHB50
NOMESCO Finland
Turbinoplasty
1.9
6.4
92
498
WX400
NOMESCO Finland
Inhalation anesthesy
1.6
6.4
166
1067
K62.6
ICD-10 Finland
Ulcer of anus and rectum
2.7
6.4
40
149
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.5
6.4
236
1642
J45.1
ICD-10 Finland
Nonallergic asthma
1.4
6.4
260
1844
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.3
6.4
557
4456
A08.3
ICD-10 Finland
Other viral enteritis
7.4
6.4
14
19
L03.3
ICD-10 Finland
Cellulitis of trunk
3.0
6.4
33
109
E03
ICD-10 Finland
Other hypothyroidism
1.4
6.4
264
1879
S06.2
ICD-10 Finland
Diffuse brain injury
2.8
6.4
38
137
XF402
NOMESCO Finland
ECG with work load test
1.3
6.4
393
2992
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.6
6.4
164
1054
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.3
6.4
526
4180
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
1.7
6.4
130
788
S04
ICPC
Lump/swelling localized
1.4
6.3
356
2672
F45.8
ICD-10 Finland
Other somatoform disorders
1.4
6.3
266
1900
A06AD11
ATC
lactulose; oral
1.3
6.3
488
3839
R04.0
ICD-10 Finland
Epistaxis
1.5
6.3
219
1504
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
1.8
6.3
99
554
L18
ICPC
Muscle pain
1.6
6.3
149
937
R83
ICPC
Respiratory infection other
1.2
6.3
933
7926
N32.82
ICD-10 Finland
Instability of the detrusor vesicae muscle
2.4
6.3
49
206
N90.3
ICD-10 Finland
Dysplasia of vulva, unspecified
11.0
6.3
11
10
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
1.7
6.2
127
769
70130
ICD-8 Finland
Other hypertrophic and atrophic conditions of the skin, Keloid scar
+∞
6.2
6
*
L95.0
ICD-10 Finland
Livedoid vasculitis
+∞
6.2
6
*
KGD00
NOMESCO Finland
Partial excision of glans penis
+∞
6.2
6
*
S01GX01
ATC
cromoglicic acid; ophthalmic
1.2
6.2
872
7365
6240A
ICD-9 Finland
Noninflammatory disorders of vulva and perineum, Dystrophy of vulva
26.7
6.2
8
*
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
1.5
6.2
184
1224
Z01.7
ICD-10 Finland
Laboratory examination
1.3
6.2
418
3227
SXA20
NOMESCO Finland
Local application of medicine to mouth
1.5
6.2
216
1487
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.3
6.2
531
4242
J45
ICD-10 Finland
Asthma
1.3
6.2
391
2994
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
1.6
6.2
149
943
XCK10
NOMESCO Finland
Photography of fundus of eye
1.4
6.2
348
2615
A10BJ06
ATC
semaglutide; parenteral
1.8
6.1
103
589
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
1.5
6.1
198
1344
J45.8
ICD-10 Finland
Mixed asthma
1.7
6.1
108
625
C10AX09
ATC
ezetimibe; oral
1.3
6.1
367
2786
D22.3
ICD-10 Finland
Melanocytic naevi of other and unspecified parts of face
1.9
6.1
83
440
N35.8
ICD-10 Finland
Other urethral stricture
7.7
6.1
13
17
G04BD09
ATC
trospium; oral
1.7
6.1
108
628
ZZA50
NOMESCO Finland
Full thickness skin graft
3.5
6.1
26
75
QBE00
NOMESCO Finland
Excision of loose skin or fold of skin from trunk
3.2
6.1
29
91
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.5
6.1
191
1287
R51
ICD-10 Finland
Headache
1.5
6.1
197
1338
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.3
6.1
542
4349
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
2.3
6.1
50
216
M13.9
ICD-10 Finland
Arthritis, unspecified
1.4
6.0
254
1817
A02BC04
ATC
rabeprazole; oral
1.4
6.0
332
2486
F43.1
ICD-10 Finland
Post-traumatic stress disorder
1.9
6.0
83
446
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
1.6
6.0
146
927
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
3.3
6.0
27
81
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
1.8
6.0
92
509

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(40768804) Tissue Pathology biopsy report
3144
21067
2.04
154.31
2.6
2.0
—
—
—
0
0
(40768443) Skin Pathology biopsy report
577
1967
3.14
129.54
1.3
1.2
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
296
805
3.82
94.10
1.6
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
1648
10600
1.77
76.60
1.6
1.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
4117
33806
1.70
74.85
5.5
4.5
e6/l
1116.9
2301.0
1.21
47
436
(3037467) Urinalysis macro (dipstick) panel - Urine
4193
34958
1.67
68.10
5.1
4.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
4548
39013
1.70
63.27
7.9
7.2
u/l
77.5
77.8
0.14
4295
36598
(3007853) Bacteria identified in Skin by Aerobe culture
899
5273
1.83
54.79
2.0
1.5
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
5271
47792
1.89
52.95
6.1
5.1
mu/l
2.3
2.0
0.34
4903
43938
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
4701
41298
1.65
52.73
5.1
4.3
pmol/l
14.8
14.8
0.39
4314
37630
(3013707) Erythrocyte sedimentation rate by Westergren method
4397
38024
1.60
52.40
4.7
4.1
mm/h
12.6
12.3
0.60
4100
35123
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
5482
50648
2.02
47.77
16.1
12.9
mg/l
21.2
22.0
1.03
4462
39745
(3000494) Fungus identified in Specimen by Culture
917
5639
1.74
47.00
1.6
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
2198
16682
1.50
46.49
3.6
3.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
2693
21401
1.47
44.71
5.1
4.3
g/l
35.9
35.8
0.39
2522
19748
(3013650) Neutrophils [#/volume] in Blood by Automated count
3486
29128
1.47
44.67
9.1
9.0
e9/l
4.0
4.0
0.20
3073
25310
(3019198) Lymphocytes [#/volume] in Blood
3123
25546
1.47
44.63
6.3
5.7
e9/l
1.9
1.9
0.16
2762
22368
(3001604) Monocytes [#/volume] in Blood
3044
24804
1.46
44.20
6.3
5.6
e9/l
0.6
0.6
0.31
2636
21260
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
3161
25984
1.46
43.60
6.0
5.9
umol/l
10.2
10.7
2.31
3006
24521
(3006315) Basophils [#/volume] in Blood
3050
24906
1.46
43.52
6.3
5.6
e9/l
0.0
0.0
0.34
2647
21349
(3009261) Glucose [Presence] in Urine by Test strip
3089
25289
1.46
43.47
4.4
3.8
estimate
0.0
0.0
1.32
593
4548
(3013115) Eosinophils [#/volume] in Blood
3135
25755
1.46
43.20
6.5
5.8
e9/l
0.2
0.2
1.42
2776
22486
(3021601) Nitrite [Presence] in Urine by Test strip
3064
25063
1.46
43.19
5.8
5.1
estimate
0.0
0.0
0.33
611
4568
(3019550) Sodium [Moles/volume] in Serum or Plasma
5563
51934
2.06
42.87
17.6
14.6
mmol/l
139.7
139.7
0.09
5444
50591
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
2583
20520
1.46
42.06
2.1
1.9
pmol/l
99.7
98.1
0.78
1297
9945
(3018095) Leukocytes [#/volume] in Urine
2246
17378
1.47
41.92
4.1
3.5
e6/l
79.6
114.0
1.83
1592
11768
(3023103) Potassium [Moles/volume] in Serum or Plasma
5570
52078
2.05
41.86
17.8
14.7
mmol/l
3.9
3.9
0.06
5433
50627
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2733
22071
1.44
40.08
3.2
2.7
ug/l
99.4
108.1
1.09
2517
20413
(3042936) Bacteria identified in Isolate by Culture
970
6303
1.64
39.85
2.1
1.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
992
6490
1.63
39.64
2.4
2.2
ug/g
139.7
123.1
0.54
781
5072
(3035350) Ketones [Presence] in Urine by Test strip
3023
24921
1.43
39.30
4.3
3.7
estimate
0.0
0.0
0.80
597
4543
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
94
209
4.55
39.12
1.6
1.8
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
5693
53910
2.23
37.40
11.9
10.1
u/l
25.3
24.9
0.57
5534
51976
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1612
11904
1.49
37.08
1.3
1.3
u/ml
1.8
1.6
0.17
432
3190
(3007164) IgA [Mass/volume] in Serum or Plasma
1403
10089
1.51
36.69
1.5
1.4
g/l
2.4
2.3
0.63
822
5950
(36304419) Bacteria [Presence] in Urine
1743
13110
1.47
36.38
3.4
2.8
—
—
—
0
0
(3002256) Pathology report gross observation
985
6557
1.60
36.36
1.3
1.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
2906
24039
1.41
35.60
6.6
5.9
%
28.8
28.6
0.33
2691
22284
(3002582) Erythrocytes [#/volume] in Urine
1883
14419
1.45
35.60
3.6
3.0
e6/l
100.6
69.5
0.29
1438
10782
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
5176
47736
1.64
35.46
14.5
12.1
ml/min/173m2
81.7
81.4
0.60
4349
39107
(3018010) Neutrophils/100 leukocytes in Blood
2870
23705
1.41
35.39
6.4
5.7
%
56.5
56.8
0.81
2663
22050
(3015377) Calcium [Moles/volume] in Serum or Plasma
2245
17778
1.42
35.19
3.5
3.3
mmol/l
2.4
2.4
1.05
1956
15464
(3019069) Monocytes/100 leukocytes in Blood
2835
23386
1.40
35.12
6.8
6.1
%
8.4
8.4
0.66
2641
21788
(3006504) Eosinophils/100 leukocytes in Blood
2820
23242
1.40
35.10
6.5
5.8
%
2.9
2.8
1.24
2607
21528
(3030467) Casts [#/volume] in Urine by Automated count
1761
13360
1.45
34.82
3.5
2.9
e6/l
0.4
0.4
0.59
1330
9864
(3022096) Basophils/100 leukocytes in Blood
2742
22513
1.40
34.78
6.6
5.9
%
0.7
0.7
0.23
2545
20881
(3044889) 12 lead EKG panel
3990
35103
1.41
32.74
4.1
3.6
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
3350
28623
1.39
32.62
4.5
4.2
mmol/l
6.6
6.6
0.15
3137
26547
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2997
25169
1.38
32.25
6.3
6.0
mmol/l
1.2
1.2
0.42
2552
21085
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
5007
46071
1.54
31.80
6.4
5.4
mmol/mol
39.7
39.3
3.25
4678
42532
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1980
15550
1.41
31.63
2.6
2.5
u/l
55.6
57.8
1.61
1842
14224
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2739
22753
1.38
31.06
5.5
5.4
mmol/l
1.2
1.2
0.08
2491
20492
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1596
12095
1.44
31.03
2.4
2.2
mg/l
2.9
3.0
0.29
1386
10326
(3026389) Candida sp identified in Specimen by Organism specific culture
193
778
2.53
31.01
1.5
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
2097
16692
1.40
30.73
6.6
5.7
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
2703
22552
1.36
29.12
2.5
2.2
nmol/l
78.2
78.5
0.25
2423
20299
(3000850) Epithelial cells [#/volume] in Urine
1351
10028
1.45
29.06
2.8
2.4
e6/l
6.5
7.1
0.96
1160
8711
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
139
502
2.81
27.79
1.3
1.1
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
1623
12552
1.40
27.50
4.5
3.5
%
93.5
93.3
0.10
1594
12210
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
397
2228
1.84
27.12
1.5
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
2660
22306
1.35
26.96
10.5
9.0
e9/l
0.0
0.0
1.03
2180
18121
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
3735
32994
1.35
26.56
3.3
3.0
u/l
45.4
43.9
0.42
3490
30632
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
5395
50891
1.63
26.46
5.4
4.8
mmol/l
2.8
2.8
2.90
4989
46793
(3018418) pH of Serum or Plasma
1899
15169
1.37
26.17
4.0
3.7
ph
7.4
7.4
0.09
348
2891
(3037522) Nuclear Ab [Titer] in Serum
982
6984
1.49
25.99
1.4
1.3
titre
530.0
561.6
0.20
223
1514
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
1120
8179
1.45
25.87
3.0
2.5
e6/l
1.0
1.7
1.33
636
4500
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
5238
49120
1.55
25.81
5.1
4.5
mmol/l
5.9
5.9
3.66
4828
44787
(40761511) CBC panel - Blood by Automated count
5544
52755
1.72
25.14
14.6
12.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
824
5701
1.52
24.84
1.3
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
1035
7498
1.46
24.82
3.2
2.7
e6/l
4.3
3.8
0.42
560
3846
(3012095) Magnesium [Moles/volume] in Serum or Plasma
1052
7650
1.46
24.73
3.6
3.1
mmol/l
0.8
0.8
0.75
971
7102
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
5304
49964
1.56
24.63
4.9
4.3
mmol/l
4.7
4.8
8.76
4949
46159
(40758558) Short blood count panel - Blood
1644
12931
1.37
24.63
7.1
6.6
—
—
—
0
0
(3035941) MCH [Entitic mass]
5821
56327
2.39
24.50
23.9
19.3
pg
30.2
30.2
0.62
5767
55526
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
1274
9609
1.41
24.49
3.0
2.9
mmol/l
2.5
2.5
1.10
1079
8413
(3024731) MCV [Entitic volume]
5821
56328
2.39
24.48
24.0
19.3
fl
90.9
90.9
0.03
5766
55531
(3026361) Erythrocytes [#/volume] in Blood
5821
56335
2.39
24.35
24.1
19.4
e12/l
4.5
4.5
0.09
5685
54698
(3000963) Hemoglobin [Mass/volume] in Blood
5822
56350
2.39
24.33
24.2
19.5
g/l
133.6
133.6
0.08
5770
55555
(3010813) Leukocytes [#/volume] in Blood
5821
56345
2.38
24.16
24.1
19.4
e9/l
6.6
6.6
0.03
5690
54700
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
5102
47728
1.48
23.91
4.3
3.8
mmol/l
1.3
1.3
2.40
4669
43489
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2751
23447
1.32
23.83
4.3
3.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1824
14645
1.35
23.79
3.4
3.0
mmol/l
6.9
6.9
0.30
1523
12224
(3007461) Platelets [#/volume] in Blood
5816
56302
2.33
23.69
24.1
19.4
e9/l
259.5
258.6
0.49
5701
54816
(3021960) Folate [Moles/volume] in Serum or Plasma
1456
11327
1.38
23.08
1.6
1.5
nmol/l
21.8
21.3
0.49
1223
9597
(3019309) Folate [Moles/volume] in Red Blood Cells
1194
8992
1.41
22.95
1.8
1.7
nmol/l
1188.1
1182.7
0.07
922
6736
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1247
9473
1.40
22.77
1.3
1.3
iu/ml
27.2
32.2
0.59
344
3032
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
5258
49596
1.51
22.53
4.7
4.3
mmol/l
1.5
1.5
8.93
4839
45587
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1432
11194
1.37
21.83
1.9
1.7
mg/l
1.1
1.1
0.31
1095
8480
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
51
114
4.50
21.21
1.9
2.1
ug/l
2.1
2.6
0.33
35
58
(3026493) Urate [Moles/volume] in Serum or Plasma
1527
12102
1.35
21.20
2.5
2.3
umol/l
4473.4
4551.2
0.03
1303
10408
(3012516) Albumin [Mass/volume] in Urine
1684
13551
1.34
21.10
3.5
3.1
mg/l
398.2
399.6
0.00
1037
7871
(3044640) Blood type and Crossmatch panel - Blood
1929
15832
1.32
21.07
2.6
2.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
2272
19082
1.31
20.98
4.6
4.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
1514
12004
1.35
20.91
4.3
3.7
—
—
—
0
0
(3026782) Osmolality of Urine
1216
9318
1.38
20.84
3.0
2.6
mosm/kgh2o
531.1
523.0
0.64
1028
7863
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
530
3462
1.58
20.53
1.6
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1756
14267
1.33
20.46
4.4
3.8
mg/mmol
7.1
7.7
0.27
1060
8353
(3025941) Bacteria identified in Stool by Culture
460
2908
1.63
20.41
1.3
1.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1794
14681
1.32
19.70
2.2
2.1
u/l
156.6
204.7
1.88
1690
13684
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
3613
32401
1.29
19.60
3.2
3.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
968
7205
1.41
19.58
1.3
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
4563
42251
1.34
19.50
19.6
16.0
%
13.6
13.7
0.16
4494
41327
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
1198
9250
1.37
19.42
4.2
3.5
ng/l
220.6
317.2
0.81
868
6875
(3022948) Iron [Moles/volume] in Serum or Plasma
967
7215
1.41
19.26
2.5
2.3
umol/l
13.5
13.1
0.98
892
6648
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
785
5657
1.45
18.95
3.0
2.5
umol/l
7.8
7.4
0.19
678
4822
(42529406) Shigella sp [Presence] in Stool by Culture
278
1562
1.82
18.91
1.3
1.2
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
341
2060
1.70
18.02
1.2
1.3
u/ml
0.3
1.1
2.42
36
197
(3014765) Yersinia sp identified in Stool by Organism specific culture
274
1560
1.79
17.85
1.3
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
614
4269
1.49
17.77
1.2
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
2210
18791
1.28
17.64
8.1
8.0
inr
1.2
1.2
0.76
659
5490
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
270
1546
1.78
17.26
1.3
1.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1931
16195
1.28
17.04
3.5
3.2
u/l
32.9
33.9
0.19
1835
15326
(3004789) Transferrin [Mass/volume] in Serum or Plasma
877
6589
1.39
16.56
2.5
2.3
g/l
2.4
2.4
0.25
798
6073
(3003327) Ova and parasites identified in Stool by Light microscopy
289
1712
1.72
16.42
1.8
1.7
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
1471
11981
1.30
16.09
4.6
3.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
719
5246
1.42
16.07
2.3
2.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
1618
13364
1.29
15.86
4.8
4.2
estimate
0.0
0.0
0.40
607
4517
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1610
13290
1.29
15.85
3.0
2.8
ng/l
1103.5
1124.3
0.08
1378
11273
(3041096) Erythrocytes [Presence] in Urine by Automated
1615
13341
1.29
15.80
3.8
3.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
626
4472
1.45
15.69
2.5
2.2
g/l
0.2
0.2
1.57
580
4180
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1648
13659
1.29
15.69
1.7
1.6
mmol/l
1.4
1.4
1.07
1358
11447
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
537
3726
1.48
15.64
2.7
3.7
u/ml
62.3
68.6
0.09
514
3591
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1462
11936
1.30
15.63
2.5
2.1
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2120
18143
1.26
15.45
3.7
3.4
ng/l
26.7
70.4
0.96
1359
11768
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1335
10784
1.31
15.42
1.8
1.6
pmol/l
40481043.6
32876082.6
0.19
1082
8885
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
648
4677
1.43
15.35
2.2
2.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
535
3726
1.48
15.29
2.1
2.3
ug/l
5.2
6.5
1.13
468
3205
(4035726)
647
4672
1.43
15.29
1.4
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1364
11089
1.30
14.95
4.4
4.3
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
810
6102
1.38
14.95
2.6
2.3
%
22.6
22.3
0.30
693
5181
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1129
8986
1.32
14.41
1.3
1.3
u/ml
9.3
12.6
0.97
403
3506
(3000570) Elastase.pancreatic [Mass/mass] in Stool
254
1518
1.70
14.01
1.4
1.4
ug/g
292.8
288.8
0.11
150
858
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1176
9448
1.30
13.97
1.6
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
367
2443
1.54
13.02
2.1
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
447
3115
1.47
12.71
2.2
1.9
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
729
5550
1.36
12.47
6.1
6.3
mmol/l
104.3
104.3
0.05
717
5440
(3027945) Reticulocytes/100 erythrocytes in Blood
643
4827
1.37
12.01
2.7
2.5
%
1.8
1.8
0.46
571
4260
(40761535) Cells panel - Urine sediment
536
3910
1.41
11.89
3.8
3.4
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
882
6953
1.32
11.86
2.7
2.0
s
30.1
29.5
1.94
858
6729
(3004716) Salmonella sp identified in Stool by Organism specific culture
390
2701
1.47
11.45
1.5
1.4
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
1027
8314
1.28
11.26
2.0
1.8
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
446
3184
1.43
11.16
1.4
1.3
u/ml
176.5
191.5
0.24
409
2937
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
394
2757
1.46
10.98
2.4
2.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
1297
10828
1.25
10.97
5.0
4.2
kg/l
1.0
1.0
0.23
176
1650
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
630
4781
1.36
10.96
2.4
2.3
u/l
30.9
48.6
1.08
532
4077
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
233
1455
1.63
10.92
1.8
1.6
g/l
1.2
1.2
0.14
224
1373
(3005719) IgG [Mass/volume] in Serum or Plasma
486
3558
1.40
10.55
2.9
2.7
g/l
10.5
10.4
0.20
447
3244
(3052851) Hemolysis interference index of Serum or Plasma
235
1491
1.60
10.34
3.3
3.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
918
7401
1.28
10.33
1.9
1.8
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
449
3255
1.41
10.32
1.3
1.3
au/ml
66.1
48.7
0.61
19
137
(3020961) Endomysium IgA Ab [Titer] in Serum
357
2482
1.47
10.29
1.1
1.1
titre
60.1
213.9
—
8
56
(3028026) IgM [Mass/volume] in Serum or Plasma
391
2777
1.44
10.08
1.8
1.9
g/l
1.3
1.4
0.97
367
2538
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
229
1455
1.60
10.03
1.2
1.3
u/ml
11.2
43.6
—
10
92
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
305
2067
1.50
9.99
2.4
2.0
u/l
40.4
39.8
0.20
274
1836
(3003458) Phosphate [Moles/volume] in Serum or Plasma
742
5843
1.31
9.97
6.0
4.7
mmol/l
1.0
1.0
0.50
693
5364
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
200
1237
1.64
9.78
1.8
1.6
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
480
3554
1.38
9.74
2.9
2.5
e9/l
70.3
70.5
0.03
365
2643
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
146
830
1.78
9.72
1.4
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
637
4929
1.33
9.70
3.5
3.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
482
3574
1.38
9.69
2.5
2.4
au/ml
19.0
25.8
0.52
20
205
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
520
3905
1.36
9.66
1.2
1.2
iu/ml
161.9
149.7
0.27
193
1474
(40761536) Microorganisms panel - Urine sediment
572
4364
1.34
9.59
4.5
3.9
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
131
724
1.83
9.58
1.5
1.5
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
210
1326
1.61
9.46
1.3
1.3
u/ml
2.8
7.3
2.33
38
215
(4010399)
486
3633
1.37
9.30
1.5
1.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
167
1011
1.67
8.91
2.6
2.9
mmol/l
24.3
25.2
2.37
149
889
(3021788) Differential panel - Synovial fluid
145
846
1.73
8.86
1.6
1.5
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
219
1422
1.56
8.78
1.9
1.6
g/l
0.2
0.2
0.55
209
1338
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
232
1528
1.54
8.73
2.2
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
390
2842
1.40
8.72
1.1
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
171
1054
1.64
8.53
1.2
1.2
u/ml
6.9
3.5
0.25
12
79
(3039162) Centromere protein B Ab [Units/volume] in Serum
116
642
1.82
8.49
1.3
1.2
u/ml
60.6
64.6
0.07
11
47
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
179
1119
1.62
8.44
1.2
1.2
u/ml
53.7
37.8
0.36
15
116
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
203
1313
1.57
8.30
1.3
1.3
u/ml
7.2
5.4
0.18
24
140
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
155
944
1.66
8.12
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
155
944
1.66
8.12
1.4
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
328
2350
1.42
8.10
1.8
1.9
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
67
311
2.17
8.09
1.6
1.5
u/ml
12.8
17.2
1.08
14
59
(3023323) Follitropin [Units/volume] in Serum or Plasma
339
2449
1.41
7.99
1.4
1.3
iu/l
28.4
32.0
1.15
283
2118
(3009343) pH of Capillary blood
358
2611
1.39
7.98
3.1
3.3
ph
7.4
7.4
0.57
63
350
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
361
2643
1.39
7.87
3.2
3.3
kpa
5.1
5.2
1.26
339
2445
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
200
1306
1.55
7.86
2.6
2.1
mg/l
11.2
11.1
0.07
189
1197
(3000492) Spirometry study
599
4730
1.30
7.84
1.5
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
345
2519
1.39
7.65
3.1
3.3
mmol/l
2.1
2.0
0.19
253
1903
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
640
5116
1.28
7.62
1.9
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
639
5114
1.28
7.53
1.9
1.7
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
224
1518
1.49
7.43
1.7
1.6
titre
142.5
258.3
—
8
72
(3049717) Cytology report of Urine Cyto stain
198
1309
1.53
7.38
2.5
2.4
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
195
1289
1.53
7.28
3.1
2.3
%
181.4
189.3
0.56
184
1233
(3014111) Lactate [Moles/volume] in Serum or Plasma
503
3920
1.31
7.27
5.1
6.2
mmol/l
1.3
1.3
0.04
490
3787
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
468
3614
1.32
7.23
3.4
3.2
pmol/l
4.4
4.5
0.53
417
3210
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
58
267
2.18
7.19
1.3
1.3
titre
66.7
69.7
—
6
30
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
66
322
2.06
7.06
1.3
1.2
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
586
4687
1.28
6.94
2.1
2.1
nmol/l
368.0
379.1
0.73
540
4295
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
663
5389
1.26
6.87
1.8
1.7
%
1.4
1.4
0.54
567
4759
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
66
326
2.04
6.85
1.3
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
279
2008
1.41
6.76
1.6
1.6
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
101
577
1.76
6.74
2.3
2.0
umol/l
7.7
7.0
0.14
80
416
(3022217) INR in Platelet poor plasma by Coagulation assay
707
5806
1.25
6.69
22.7
22.6
inr
1.2
1.3
1.53
122
833
(3009542) Hematocrit [Volume Fraction] of Blood
4796
46214
1.19
6.62
17.8
14.2
%
39.7
39.4
2.10
3475
33405
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
494
3894
1.29
6.57
2.8
2.8
ng/l
158.4
167.8
0.29
444
3519
(3003396) Base excess in Arterial blood by calculation
614
4980
1.26
6.48
5.6
6.8
mmol/l
1.1
1.2
0.31
473
3953
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
204
1401
1.47
6.38
3.9
2.1
%
94.9
93.8
0.31
194
1292
(3021901) Oxygen saturation in Capillary blood
121
740
1.65
6.33
2.3
2.7
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
267
1931
1.40
6.32
1.9
1.5
u/ml
21.3
13.8
—
8
50
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
227
1595
1.44
6.31
1.5
1.4
pmol/l
90.9
180.0
5.25
220
1558
(3013139) Helicobacter pylori Ag [Presence] in Stool
468
3684
1.29
6.29
1.3
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
527
4216
1.27
6.24
1.7
1.7
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
476
3761
1.29
6.22
2.4
2.5
g/l
66.7
66.7
0.01
441
3393
(3002179) Metamyelocytes/100 leukocytes in Blood
475
3761
1.29
6.11
3.6
3.8
%
0.5
0.6
0.38
115
790
(3017143) Hepatitis C virus Ab [Presence] in Serum
654
5379
1.24
6.10
1.6
1.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
470
3718
1.29
6.09
3.9
4.1
%
0.0
0.3
1.47
117
845
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
200
1382
1.46
6.08
2.6
2.0
ug/l
242.6
492.2
2.21
181
1270
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
191
1311
1.47
6.02
1.2
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
145
940
1.56
5.98
2.6
3.1
kpa
8.5
8.3
0.47
137
869
(3030981) Hyaline casts [#/volume] in Urine by Automated count
303
2261
1.36
5.94
2.8
2.5
e6/l
0.2
0.3
0.82
296
2186
(3013512) EKG study
1603
14339
1.16
5.91
3.8
3.7
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
544
4400
1.26
5.88
5.9
7.3
%
95.8
95.8
0.03
525
4230
(3036489) Thrombin time
240
1728
1.41
5.85
2.7
1.9
s
22.3
21.2
1.31
213
1497
(3027944) Amphetamines [Presence] in Urine
228
1638
1.41
5.64
1.8
1.9
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
117
733
1.61
5.61
1.4
1.4
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
510
4119
1.26
5.59
6.2
7.6
g/l
120.8
120.4
0.17
488
3958
(3024891) Influenza virus A+B Ag [Presence] in Specimen
178
1224
1.47
5.58
1.1
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
231
1669
1.40
5.54
2.0
2.0
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
231
1673
1.40
5.47
2.0
2.0
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
606
5003
1.24
5.46
5.6
6.8
kpa
5.1
5.1
0.80
573
4763
(3027801) Oxygen [Partial pressure] in Arterial blood
605
5001
1.23
5.39
5.6
6.8
kpa
12.2
12.6
1.14
574
4762
(3020779) Urea [Moles/volume] in Serum or Plasma
448
3579
1.27
5.39
7.5
6.3
mmol/l
9.0
9.0
0.03
426
3406
(3004588) Protein electrophoresis panel - Serum or Plasma
392
3087
1.29
5.29
2.2
2.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
507
4121
1.25
5.27
3.9
4.0
%
0.8
0.8
0.09
143
1088
(3000764) Benzodiazepines [Presence] in Urine
228
1659
1.39
5.26
2.0
2.0
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
109
683
1.61
5.25
1.2
1.2
u/ml
3.7
4.4
0.24
53
285
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
142
948
1.51
5.18
2.4
2.4
ug/min
39.7
69.1
1.25
72
548
(4062490)
85
502
1.70
5.15
1.4
1.4
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
184
1295
1.43
5.14
4.0
2.4
g/l
3.5
3.6
0.36
175
1229
(3027135) IgG subclass 1 [Mass/volume] in Serum
85
504
1.70
5.08
1.5
1.4
g/l
7.3
6.7
0.55
68
350
(3024139) IgG subclass 3 [Mass/volume] in Serum
85
504
1.70
5.08
1.5
1.4
g/l
0.4
0.4
0.97
68
350
(3028192) IgG subclass 2 [Mass/volume] in Serum
85
504
1.70
5.08
1.5
1.4
g/l
2.7
2.8
0.32
68
351
(3014051) Protein [Presence] in Urine by Test strip
175
1226
1.44
5.02
2.0
2.1
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
212
1537
1.39
5.02
2.0
2.0
—
—
—
0
0
(3003338) MCHC [Mass/volume]
4464
43036
1.15
5.00
21.4
16.9
g/l
331.2
331.5
1.31
4443
42733
(3006184) Hemoglobin [Mass/volume] in Capillary blood
152
1038
1.48
4.98
2.0
2.2
g/l
131.6
128.6
0.79
109
745
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
175
1230
1.44
4.94
1.5
1.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
518
4261
1.24
4.85
3.5
3.4
mmol/l
1.2
1.2
0.26
448
3688
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
92
567
1.63
4.77
1.7
1.5
%
52.4
55.7
0.31
50
352
(3024980) IgG subclass 4 [Mass/volume] in Serum
120
789
1.53
4.73
1.5
1.6
g/l
0.6
0.7
1.65
100
593
(3000991) Gas panel - Venous blood
453
3682
1.25
4.73
7.3
7.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
820
7070
1.19
4.71
1.6
1.6
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
345
2720
1.28
4.65
6.1
6.9
mmol/l
24.7
24.8
0.17
315
2518
(3021440) Promyelocytes/100 leukocytes in Blood
479
3935
1.24
4.55
3.8
4.0
%
0.1
0.2
0.41
130
1005
(3022475) Manganese [Moles/volume] in Blood
13
34
3.83
4.53
1.2
1.2
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
229
1714
1.35
4.49
2.3
2.1
nmol/l
10.7
12.2
1.50
204
1513
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
587
4933
1.21
4.46
3.9
4.0
u/l
232.8
246.0
1.98
552
4643
(1617658) Protocol used for examination of sentinel lymph nodes
91
570
1.61
4.45
1.1
1.0
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
66
380
1.75
4.43
1.2
1.2
titre
87.5
184.2
1.59
12
76
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
479
3947
1.23
4.43
3.6
3.2
ng/l
83.2
80.3
0.34
422
3316
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
330
2605
1.28
4.42
1.5
1.4
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
483
3988
1.23
4.38
4.6
3.5
kpa
5.8
5.8
0.28
472
3883
(3000475) Leukocytes [#/volume] in Synovial fluid
159
1128
1.42
4.32
1.6
1.6
e6/l
10664.5
11730.4
0.12
104
810
(3003694) ABO and Rh group [Type] in Blood
1499
13601
1.14
4.31
1.5
1.4
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
203
1506
1.36
4.23
2.1
2.3
g/l
0.3
0.8
3.73
177
1290
(3008898) HLA-B27 [Presence]
241
1835
1.33
4.23
1.0
1.1
—
—
—
0
0
(3019060) Gas panel - Arterial blood
351
2809
1.27
4.22
4.2
4.9
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
129
886
1.47
4.17
1.5
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
169
1222
1.39
4.13
2.0
1.8
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
124
847
1.47
4.13
1.3
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
478
3969
1.22
4.12
4.7
3.5
mmol/l
1.9
2.0
0.28
395
3252
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
341
2729
1.26
4.10
6.9
8.2
%
0.7
0.7
0.02
341
2712
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
462
3826
1.22
4.09
2.5
2.5
ml/min/173m2
67.6
66.5
0.27
186
1488
(3016650) Hepatitis A virus Ab [Presence] in Serum
114
768
1.49
4.07
1.1
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
137
957
1.44
4.07
3.1
3.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
177
1296
1.38
4.02
2.0
2.0
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
52
289
1.81
3.97
1.1
1.5
u/l
4.9
5.7
0.85
44
238
(3028707) Methadone [Presence] in Urine by Screen method
109
733
1.50
3.94
2.7
2.6
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
404
3313
1.24
3.93
3.8
3.1
kpa
4.6
4.5
0.36
392
3213
(1002224) Polysomnography panel
248
1918
1.31
3.92
1.1
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
192
1431
1.35
3.92
1.3
1.2
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
136
957
1.43
3.90
2.8
2.4
%
16.6
16.4
0.32
79
475
(3000330) Specific gravity of Urine by Test strip
316
2525
1.27
3.87
3.8
3.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
127
885
1.44
3.84
1.5
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
154
1115
1.39
3.77
1.3
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
57
331
1.73
3.77
2.1
1.9
—
—
—
0
0
(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma
12
34
3.53
3.76
1.1
1.1
mg/l
38.6
40.8
—
5
12
(3034770) Mitochondria Ab [Titer] in Serum
183
1366
1.35
3.71
1.4
1.2
titre
800.9
1030.0
0.31
11
53
(3019420) Tryptase [Mass/volume] in Serum or Plasma
46
252
1.83
3.70
1.7
1.6
ug/l
7.7
8.4
0.11
40
220
(3047007) Chlamydophila sp Ab [Presence] in Serum
109
744
1.47
3.69
1.2
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
117
810
1.45
3.68
1.5
1.3
u/ml
111.9
116.9
0.20
24
163
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
216
1655
1.32
3.67
2.1
2.2
g/l
3.1
3.1
0.46
169
1275
(40759836) Histone Ab [Presence] in Serum by Immunoblot
64
389
1.65
3.60
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
64
390
1.65
3.57
1.2
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
64
390
1.65
3.57
1.2
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
27
124
2.18
3.53
1.1
1.1
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
227
1763
1.30
3.51
2.2
2.2
u/l
6358.8
5575.2
0.10
75
720
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
64
392
1.64
3.50
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
64
392
1.64
3.50
1.2
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
28
132
2.13
3.44
1.4
1.3
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
64
394
1.63
3.44
1.2
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
33
166
1.99
3.43
1.2
1.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
23
100
2.31
3.42
1.5
1.1
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
46
259
1.78
3.41
1.1
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
626
5424
1.17
3.40
3.6
4.0
ug/l
4.8
24.2
4.12
477
4337
(3023183) Ammonium ion [Moles/volume] in Plasma
116
815
1.43
3.40
2.8
2.8
umol/l
32.6
33.9
0.20
99
696
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
128
917
1.40
3.37
1.3
1.2
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
66
412
1.61
3.37
1.6
1.5
%
38.5
34.2
0.36
31
252
(3020891) Body temperature
225
1757
1.29
3.36
4.1
4.4
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
52
306
1.71
3.32
1.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
16
59
2.72
3.31
3.2
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
111
779
1.43
3.29
1.1
1.1
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
178
1352
1.33
3.26
1.3
1.2
titre
115.9
153.9
0.27
17
122
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
154
1145
1.35
3.25
5.5
3.4
mg/l
1.5
1.4
0.11
138
1052
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
224
1757
1.29
3.24
2.0
2.1
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
30
149
2.02
3.24
1.0
1.1
%
95.6
91.6
0.25
15
64
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
224
1760
1.28
3.20
2.0
2.1
g/l
7.5
7.5
0.17
177
1311
(3009214) Lutropin [Units/volume] in Serum or Plasma
148
1097
1.36
3.20
1.5
1.4
u/l
12.9
12.9
0.01
114
899
(3043409) Potassium [Moles/volume] in Arterial blood
173
1314
1.33
3.18
4.0
4.0
mmol/l
3.8
3.8
1.02
163
1238
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
121
870
1.40
3.15
1.4
1.2
u/ml
293.0
256.8
0.57
72
523
(3034891) Synovial lining cells/100 cells in Synovial fluid
40
222
1.81
3.13
1.4
1.5
%
5.9
3.7
—
8
49
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
208
1625
1.29
3.12
1.9
1.9
ug/l
3.0
1.8
0.71
188
1439
(3014148) Varicella zoster virus Ab [Titer] in Serum
86
583
1.48
3.07
1.1
1.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
26
125
2.08
3.07
1.8
1.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
181
1392
1.31
3.06
1.2
1.2
—
—
—
0
0
(4094501)
168
1279
1.32
3.05
1.1
1.1
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
118
850
1.40
3.05
1.2
1.2
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
195
1516
1.30
3.04
1.6
1.6
iu/ml
0.2
0.3
0.03
58
314
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
277
2248
1.24
3.04
6.8
8.5
mmol/l
24.2
24.5
0.63
257
2110
(3011288) Drugs identified in Urine by Screen method
153
1152
1.34
3.00
2.8
2.8
—
—
—
0
0
(4268621)
73
481
1.52
2.99
2.2
2.2
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
118
855
1.39
2.96
1.8
1.8
nmol/l
0.9
0.8
0.34
100
719
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
328
2719
1.22
2.95
1.7
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
400
3381
1.20
2.94
3.3
3.1
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
30
155
1.94
2.93
29.6
24.0
ug/l
120.5
114.5
0.18
22
125
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
188
1463
1.29
2.93
1.1
1.1
u/ml
6.4
5.7
0.07
20
164
(3003721) Smooth muscle Ab [Units/volume] in Serum
11
35
3.15
2.92
1.0
1.3
—
2.2
—
0
8
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
221
1756
1.27
2.92
2.0
2.1
g/l
3.8
3.8
0.06
165
1240
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
604
5288
1.16
2.90
5.0
4.4
ug/l
2.3
2.4
0.09
538
4730
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
56
350
1.61
2.89
1.9
1.9
%
13.7
13.8
0.04
32
152
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
108
775
1.40
2.88
1.2
1.3
nmol/l
0.1
0.3
—
7
44
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
56
351
1.60
2.86
1.4
1.5
umol/l
9.7
11.7
2.40
56
333
(4306422)
100
709
1.42
2.85
1.1
1.2
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
29
150
1.94
2.84
1.5
1.3
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
254
2059
1.24
2.84
5.3
3.9
mmol/l
24.3
24.3
0.14
232
1855
(3010421) pH of Blood
159
1216
1.32
2.83
3.5
3.4
ph
7.4
7.4
0.73
132
1000
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
142
1070
1.34
2.80
1.4
1.3
mmol/l
3.7
3.7
0.21
131
1009
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
28
144
1.95
2.79
1.0
1.2
%
105.2
94.5
0.91
13
65
(3020393) Adenovirus Ag [Presence] in Stool
14
53
2.65
2.79
1.5
1.0
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
86
596
1.45
2.78
1.7
1.5
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
172
1333
1.30
2.78
1.9
2.2
g/l
0.0
0.0
1.01
164
1213
(3037121) Protein [Mass/volume] in Urine
205
1625
1.27
2.78
2.8
3.0
g/l
0.3
0.3
0.25
91
590
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
107
772
1.39
2.77
1.1
1.1
—
—
—
0
0
(3012565) Volume of 24 hour Urine
41
239
1.72
2.76
1.8
2.3
ml
2127.7
1921.4
0.57
35
213
(3029075) Extractable nuclear Ab panel - Serum
27
138
1.96
2.74
1.0
1.1
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
37
210
1.77
2.73
2.6
2.2
ug/min
32.9
134.3
—
7
42
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
40
233
1.72
2.71
1.2
1.1
u/ml
1.7
30.0
—
6
22
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
38
219
1.74
2.67
1.2
1.1
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
8
19
4.22
2.67
6.0
2.5
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
61
399
1.53
2.63
1.1
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
233
1891
1.24
2.60
3.3
3.4
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
181
1426
1.28
2.60
1.3
1.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
209
1676
1.26
2.60
3.5
3.5
mmol/l
25.1
25.1
0.05
197
1534
(3045462) Protein/Creatinine [Ratio] in Urine
11
38
2.90
2.58
4.0
5.6
g/mol
64.2
74.9
0.13
11
33
(3017732) Neutrophils [#/volume] in Blood
408
3499
1.18
2.57
2.5
2.8
e9/l
3.9
4.0
0.30
319
2748
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
157
1220
1.29
2.52
1.7
2.2
g/l
0.0
0.0
0.00
150
1122
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
58
380
1.53
2.50
1.1
1.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
159
1240
1.29
2.49
1.7
2.2
g/l
0.0
0.0
0.50
151
1125
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
94
678
1.39
2.48
1.2
1.3
nmol/l
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
54
349
1.55
2.47
1.1
1.1
iu/ml
4.2
10.3
2.47
13
85
(3022493) Free Hemoglobin [Mass/volume] in Plasma
29
158
1.84
2.47
4.1
5.6
mg/l
90.5
62.6
0.54
24
114
(3051611) Lipemic interference index of Serum or Plasma
76
528
1.45
2.47
3.6
3.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
18
82
2.20
2.47
1.3
1.1
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
64
430
1.49
2.46
2.0
2.3
e9/l
1.2
1.2
0.18
44
268
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
15
63
2.38
2.46
1.0
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
185
1476
1.26
2.42
1.3
1.4
—
—
—
0
0
(3017937) Magnesium [Moles/time] in 24 hour Urine
6
12
5.00
2.40
1.2
1.4
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
95
691
1.38
2.40
1.1
1.1
%
126.2
120.9
0.98
90
614
(4024509)
78
548
1.43
2.40
1.6
1.6
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
198
1595
1.25
2.39
1.7
1.7
mu/l
290.9
311.7
0.54
180
1433
(3012501) Base excess in Blood by calculation
133
1020
1.31
2.37
3.7
3.5
mmol/l
2.6
2.7
0.14
95
703
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
176
1400
1.26
2.37
1.7
2.1
g/l
38.2
37.8
0.50
157
1181
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
5
8
6.25
2.37
5.4
4.0
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
5
8
6.25
2.37
5.4
4.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
99
729
1.36
2.33
1.1
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
405
3503
1.17
2.32
1.4
1.4
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
26
140
1.86
2.31
1.8
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
97
714
1.36
2.29
1.2
1.3
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
202
1640
1.24
2.29
1.9
2.1
g/l
9.6
10.2
1.44
174
1363
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
14
59
2.38
2.29
1.1
1.4
nmol/l
7.3
667354.8
—
7
49
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
32
185
1.73
2.27
1.4
1.3
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
229
1887
1.22
2.26
1.6
1.7
g/l
1.6
1.6
0.01
187
1611
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
44
278
1.59
2.24
2.0
2.5
e9/l
0.3
0.2
0.64
36
233
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
97
717
1.36
2.24
1.1
1.1
u/ml
2.1
3.8
1.29
45
314
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
73
514
1.43
2.24
6.6
6.3
mg/l
11.7
11.8
0.09
66
477
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
51
334
1.53
2.23
1.2
1.2
u/l
114.0
79.4
0.52
45
293
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
97
718
1.36
2.22
2.0
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
48
311
1.55
2.21
1.3
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
279
2350
1.20
2.21
7.1
9.2
—
—
—
0
0
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
10
36
2.78
2.20
4.0
3.0
—
—
—
0
0
(3019977) pH of Arterial blood
38
233
1.63
2.19
3.3
3.1
ph
7.4
7.4
0.25
14
77
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
86
626
1.38
2.19
1.1
1.1
—
—
—
0
0
(44813793)
55
368
1.50
2.19
1.1
1.1
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
35
210
1.67
2.19
1.2
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
35
210
1.67
2.19
1.2
1.3
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
7
19
3.69
2.15
1.0
1.4
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
102
766
1.34
2.14
1.4
1.4
nmol/l
0.3
0.4
0.60
83
566
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
26
144
1.81
2.14
2.0
1.6
ug/l
9.1
8.8
0.19
26
144
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
95
706
1.35
2.13
1.2
1.2
u/ml
3.6
4.3
0.13
29
221
(3000060) B lymphocytes [#/volume] in Blood
23
123
1.87
2.11
2.8
2.0
e6/l
279.3
158.1
0.62
14
68
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
639
5756
1.12
2.05
1.7
1.7
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
49
326
1.51
2.03
1.2
1.2
u/l
18.4
22.8
0.31
39
277
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
138
1091
1.27
2.01
1.4
1.4
e6/l
22.5
40.5
0.59
101
846
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
38
239
1.59
2.01
1.0
1.1
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
44
287
1.54
1.99
2.0
2.4
e6/l
588.3
477.4
0.92
35
235
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
679
6153
1.12
1.97
7.5
6.3
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
138
1094
1.27
1.97
1.5
1.4
e6/l
4295.9
1223.6
0.62
108
897
(3017315) Amylase [Enzymatic activity/volume] in Urine
41
264
1.56
1.97
1.1
1.2
u/l
129.5
281.6
2.46
35
244
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
27
156
1.73
1.96
2.4
2.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
58
403
1.44
1.95
1.5
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
47
314
1.50
1.92
1.1
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
68
490
1.39
1.88
1.6
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
72
524
1.38
1.88
1.5
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
43
284
1.52
1.86
1.2
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
38
244
1.56
1.86
1.2
1.8
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
219
1838
1.20
1.85
4.2
5.2
%
1.7
1.6
1.25
202
1717
(3028717) Thiamine [Mass/volume] in Blood
11
46
2.39
1.85
1.3
1.2
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
10
40
2.50
1.83
4.1
2.8
mg/l
22.9
21.2
—
10
40
(3044009) aPTT.lupus sensitive (LA screen)
10
40
2.50
1.83
1.2
1.2
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
238
2015
1.19
1.83
2.7
2.7
%
0.7
0.7
0.26
230
1933
(3013293) Extractable nuclear Ab [Presence] in Serum
16
80
2.00
1.79
1.5
1.4
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
24
138
1.74
1.79
1.0
1.1
u/ml
5.5
1.5
0.72
11
72
(3016038) Potassium [Moles/volume] in Urine
48
328
1.47
1.78
1.2
1.1
mmol/l
34.2
34.5
0.03
38
280
(3034426) Prothrombin time (PT)
27
161
1.68
1.77
1.2
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
169
1390
1.22
1.77
3.1
2.7
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
33
208
1.59
1.76
3.6
2.2
ug/l
14.5
299.2
0.98
28
190
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
528
4752
1.12
1.75
1.4
1.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
151
1229
1.23
1.75
1.5
1.3
mg/l
549.0
525.8
0.14
144
1167
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
33
209
1.58
1.73
2.2
2.1
umol/l
209.1
145.3
0.47
14
112
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
38
249
1.53
1.72
1.2
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
32
202
1.59
1.70
1.2
1.1
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
48
2.29
1.70
5.6
5.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
20
111
1.80
1.68
1.2
1.2
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
57
408
1.40
1.67
1.6
1.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
107
843
1.27
1.66
8.7
4.5
iu/ml
2347.9
677.8
0.41
23
99
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
8
31
2.58
1.65
3.0
2.4
mg/l
3.8
3.3
—
8
31
(3020650) Glucose [Presence] in Urine
23
134
1.72
1.65
1.3
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
161
1329
1.22
1.65
5.3
3.0
u/ml
0.3
0.4
0.89
91
757
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
83
633
1.32
1.64
1.3
1.3
pmol/l
333.3
334.4
0.01
66
491
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
43
293
1.47
1.64
1.2
1.3
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
61
444
1.38
1.63
1.6
1.5
—
—
—
0
0
(3019174) dRVVT (LA screen)
10
43
2.33
1.60
1.2
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
56
404
1.39
1.59
4.2
3.5
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
114
911
1.26
1.58
3.2
3.2
nmol/l
0.8
0.8
0.14
91
711
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
27
167
1.62
1.57
1.1
1.2
%
120.9
111.5
0.74
21
148
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
220
1879
1.18
1.57
1.9
1.8
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
38
255
1.49
1.57
1.3
1.2
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
214
1825
1.18
1.56
4.4
5.3
%
0.9
0.9
0.02
197
1706
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
87
674
1.30
1.55
1.1
1.1
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
12
57
2.11
1.54
2.0
1.6
ug/l
109.0
109.0
0.00
12
49
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
28
176
1.59
1.54
1.2
1.2
g/l
0.3
0.3
1.24
21
142
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
202
1718
1.18
1.52
1.9
1.7
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
67
885
0.75
1.52
1.7
1.7
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
55
400
1.38
1.50
1.5
2.1
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
25
154
1.63
1.49
1.7
1.7
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
72
547
1.32
1.49
1.1
1.2
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
71
539
1.32
1.48
1.3
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
110
884
1.25
1.48
3.8
3.1
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
49
351
1.40
1.47
2.4
2.5
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
12
59
2.04
1.43
1.0
1.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
52
379
1.38
1.42
1.1
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
87
684
1.28
1.41
1.6
1.4
mu/l
57.1
51.3
0.16
72
607
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
124
1017
1.22
1.40
1.7
1.5
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
74
571
1.30
1.39
1.1
1.2
u/l
56.6
62.4
0.53
56
388
(3033923) Metanephrine [Moles/time] in 24 hour Urine
19
111
1.71
1.38
1.1
1.1
umol/24h
0.6
0.7
—
10
55
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
9
41
2.20
1.36
1.0
1.0
—
—
—
0
0
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
9
41
2.20
1.36
1.3
2.6
pmol/l
—
22.4
—
0
12
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
77
600
1.29
1.35
1.2
1.1
g/l
1.5
1.5
0.26
71
539
(3023511) Choriogonadotropin [Units/volume] in Urine
112
913
1.23
1.35
1.3
1.3
—
—
—
0
0
(3017704) Immunofixation for Urine
32
215
1.49
1.35
1.8
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
81
636
1.28
1.34
1.4
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
60
452
1.33
1.34
1.0
1.1
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
73
566
1.29
1.33
1.8
1.5
—
—
—
0
0
(3010015) Selenium [Moles/volume] in Serum or Plasma
9
42
2.14
1.33
1.7
1.9
umol/l
1.5
1.3
—
9
37
(3019225) pH of Specimen
551
5055
1.10
1.33
4.3
4.0
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
16
90
1.78
1.32
1.3
1.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
123
1015
1.22
1.32
1.4
1.4
—
—
—
0
0
(44806118)
62
471
1.32
1.31
1.7
1.4
—
—
—
0
0
(44790049)
62
471
1.32
1.31
1.7
1.4
—
—
—
0
0
(44790048)
62
471
1.32
1.31
1.7
1.4
—
—
—
0
0
(44790047)
62
471
1.32
1.31
1.7
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
19
113
1.68
1.31
1.2
2.0
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
87
692
1.26
1.31
2.3
3.3
%
1.2
1.4
0.23
71
551
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
90
719
1.26
1.30
1.8
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
82
648
1.27
1.30
1.4
1.4
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
9
43
2.09
1.30
1.0
1.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
395
4365
0.90
1.29
1.7
1.7
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
74
578
1.28
1.29
1.3
1.4
ug/l
2.7
3.8
1.24
59
493
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
16
91
1.76
1.28
1.2
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
41
293
1.40
1.28
4.7
3.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
37
260
1.43
1.26
1.0
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1849
17773
1.06
1.26
2.9
2.8
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
162
1381
1.18
1.24
1.3
1.2
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
6
25
2.40
1.24
1.0
1.1
—
—
—
0
0
(4034850)
195
1688
1.16
1.24
12.3
9.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
119
987
1.21
1.23
1.8
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
61
468
1.31
1.23
1.2
1.7
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
22
139
1.58
1.22
1.3
1.2
g/l
38.8
38.1
—
10
69
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
10
49
2.04
1.22
4.8
2.3
u/field
0.4
0.7
—
10
49
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
61
470
1.30
1.19
1.9
1.6
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
77
612
1.26
1.19
1.4
1.3
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
120
1001
1.20
1.19
2.8
3.3
u/ml
61.8
696.7
1.67
106
913
(3027974) Hepatitis B virus e Ag [Presence] in Serum
6
26
2.31
1.18
1.0
1.7
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
16
94
1.70
1.17
1.4
1.5
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
62
481
1.29
1.16
1.4
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
79
632
1.25
1.16
1.5
1.4
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
107
885
1.21
1.16
1.5
1.3
mmol/l
69.1
63.1
0.85
90
709
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
33
0.00
1.16
0.0
1.0
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
66
517
1.28
1.15
1.8
1.6
titre
10864.0
1210.0
—
5
8
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
79
633
1.25
1.15
1.5
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
79
633
1.25
1.15
1.5
1.4
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
58
447
1.30
1.14
1.3
1.2
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
19
118
1.61
1.14
1.5
1.4
%
25.8
37.1
0.84
11
79
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
47
352
1.34
1.13
1.6
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
55
422
1.31
1.12
1.1
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
104
861
1.21
1.12
1.5
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
79
635
1.25
1.12
1.5
1.4
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
11
58
1.90
1.12
1.0
1.0
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
457
4200
1.10
1.10
4.2
3.8
%
20.9
21.2
0.16
182
1832
(3008295) Osmolality of Serum or Plasma
65
513
1.27
1.08
1.9
1.4
mosm/kgh2o
276.9
276.7
0.02
48
384
(3013247) Albumin in CSF/Albumin in Serum or Plasma
15
89
1.69
1.07
1.1
1.1
mg/g
5.5
7.0
0.82
15
84
(4211845)
36
261
1.38
1.07
2.6
3.3
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
161
1393
1.16
1.07
3.1
3.2
mg/l
32.6
39.3
0.56
130
1120
(4146454)
63
497
1.27
1.06
2.2
2.6
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
161
1394
1.16
1.06
3.1
3.2
mg/l
40.6
95.7
0.74
130
1123
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
60
471
1.28
1.05
2.5
2.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
24
162
1.48
1.03
1.3
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
30
212
1.42
1.03
1.0
1.1
miu/ml
1512.2
1566.8
0.13
30
212
(3027570) Oxalate [Moles/time] in 24 hour Urine
5
22
2.27
1.03
1.0
1.8
umol/24h
277.4
338.3
—
5
22
(3011648) Oxygen content in Venous blood
47
358
1.32
1.03
2.1
2.9
%
11.3
10.9
0.26
47
358
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
17
106
1.61
1.02
1.6
2.4
mmol/l
6.5
7.0
0.33
11
62
(3006270) Folate [Moles/volume] in Blood
55
429
1.28
1.02
1.2
1.1
nmol/l
375.7
365.5
0.14
49
373
(3038177) Helicobacter pylori Ab [Presence] in Serum
102
853
1.20
1.02
1.2
1.2
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
9
47
1.92
1.02
2.0
2.2
—
—
—
0
0
(3034459) Mononuclear cells/100 leukocytes in Pleural fluid
9
47
1.92
1.02
2.4
1.4
%
76.3
76.6
—
9
41
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
41
307
1.34
1.01
1.2
1.1
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
34
247
1.38
1.01
2.8
1.8
u/field
1.2
3.2
1.32
27
176
(44806420)
20
131
1.53
0.99
2.3
2.3
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
13
76
1.71
0.98
1.8
1.9
mmol/l
3.2
2.5
0.43
13
66
(3013945) Hepatitis B virus e Ab [Presence] in Serum
5
23
2.17
0.98
1.0
1.8
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
106
894
1.19
0.98
2.0
1.6
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
29
0.00
0.97
0.0
1.0
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
7
36
1.95
0.97
1.1
1.0
u/l
7.1
14.7
—
7
36
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
15
92
1.63
0.97
1.1
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
67
540
1.24
0.96
1.0
1.1
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
9
50
1.80
0.96
2.0
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
121
1034
1.17
0.96
3.2
3.3
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
17
108
1.58
0.96
1.1
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
33
241
1.37
0.96
2.7
3.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
71
577
1.23
0.95
1.7
1.4
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
7
37
1.89
0.94
1.1
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
420
4542
0.92
0.94
1.3
1.3
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
115
982
1.17
0.93
1.2
1.2
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
9
52
1.73
0.92
2.0
1.6
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
24
167
1.44
0.91
2.0
2.4
—
—
—
0
0
(3004593) Baker's yeast IgA Ab [Units/volume] in Serum
6
28
2.14
0.91
1.0
1.2
—
29.3
—
0
8
(3024471) HLA-A [Type]
19
126
1.51
0.91
1.0
1.0
—
—
—
0
0
(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
6
29
2.07
0.89
1.0
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
62
502
1.24
0.88
1.1
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
48
377
1.28
0.87
1.5
1.3
u/ml
0.2
1.1
1.47
25
166
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
10
56
1.79
0.87
1.1
1.2
umol/24h
1.3
1.6
—
10
56
(3017509) Phencyclidine [Presence] in Urine
8
43
1.86
0.87
1.6
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
308
2817
1.10
0.87
1.7
1.7
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
6
30
2.00
0.87
1.0
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
138
1205
1.15
0.86
5.2
4.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
71
586
1.21
0.85
3.5
2.7
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
18
120
1.50
0.85
1.1
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
18
120
1.50
0.85
1.1
1.1
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
18
120
1.50
0.85
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
18
120
1.50
0.85
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
18
120
1.50
0.85
1.1
1.1
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
18
120
1.50
0.85
1.1
1.2
pmol/l
301.8
299.9
0.01
12
88
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
13
80
1.63
0.84
2.0
1.4
%
30.3
21.5
0.43
13
67
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
6
31
1.94
0.84
1.0
1.0
mmol/l
8.5
8.2
—
6
31
(3035320) C reactive protein [Mass/volume] in Body fluid
46
362
1.27
0.83
2.7
2.3
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
92
1081
0.85
0.83
4.1
3.4
mg/l
23.9
24.8
0.08
56
669
(3035933) Granulocytes/100 leukocytes in Blood
8
137
0.58
0.83
1.0
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
114
985
1.16
0.82
1.8
1.7
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
46
1.74
0.82
1.0
1.1
—
—
—
0
0
(3025315) Body weight
6
32
1.88
0.81
4.2
4.0
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
30
223
1.35
0.81
2.2
2.7
%
35.2
41.6
0.82
13
71
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
178
1588
1.12
0.81
1.3
1.3
miu/ml
192.6
227.1
0.73
97
769
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
153
1352
1.14
0.81
3.2
3.1
ratio
1.1
1.4
1.17
14
115
(40757373) Influenza virus identified in Isolate
13
81
1.61
0.81
1.6
1.6
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
159
1409
1.13
0.81
5.2
6.3
mmol/l
1.3
1.2
0.33
132
1232
(3002523) Influenza virus A Ag [Presence] in Specimen
87
738
1.18
0.79
1.1
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
87
739
1.18
0.78
1.1
1.1
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
24
173
1.39
0.78
1.0
1.1
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
13
82
1.59
0.78
2.1
1.5
—
—
—
0
0
(4198724)
25
182
1.38
0.77
1.4
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
45
358
1.26
0.77
1.4
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
45
358
1.26
0.77
1.4
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
45
358
1.26
0.77
1.4
1.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
34
261
1.30
0.76
1.9
1.5
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
16
233
0.69
0.76
1.9
1.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
208
1882
1.11
0.75
2.3
1.7
mg/l
4.9
3.8
0.43
155
1335
(3003888) Timothy IgE Ab [Units/volume] in Serum
100
863
1.16
0.75
1.1
1.1
u/ml
5.9
4.6
0.33
60
431
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
28
209
1.34
0.75
2.1
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
28
209
1.34
0.75
2.1
1.7
—
—
—
0
0
(3024932) HLA-DR beta [Type]
18
124
1.45
0.75
1.1
1.1
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
5
24
2.08
0.74
3.6
2.0
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
9
54
1.67
0.74
2.0
2.1
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
31
236
1.32
0.74
1.1
1.6
nmol/l
5.1
4.4
0.10
21
189
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
163
1458
1.12
0.73
2.0
1.8
iu/l
5.9
4.3
0.47
64
533
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
9
55
1.64
0.73
1.1
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
46
370
1.25
0.72
5.6
6.2
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
5
25
2.00
0.72
1.0
1.1
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
9
56
1.61
0.72
1.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
54
443
1.22
0.72
1.1
1.1
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
40
317
1.26
0.71
2.2
2.3
ml
683.6
630.2
0.35
28
209
(3020191) Ethanol [Moles/volume] in Serum or Plasma
41
326
1.26
0.71
1.4
1.4
promille
1.3
1.2
0.24
28
242
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
16
109
1.47
0.70
1.2
1.1
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
16
109
1.47
0.70
1.0
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
52
426
1.22
0.70
1.4
1.3
e6/l
31499.3
136116.9
1.75
30
289
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
9
58
1.55
0.69
1.0
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
30
230
1.31
0.69
1.9
1.6
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
7
42
1.67
0.68
1.0
1.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
60
501
1.20
0.68
3.5
3.5
mmol/l
7.0
7.3
0.31
45
418
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
65
547
1.19
0.68
4.2
4.7
u/ml
339.9
77.3
0.60
19
156
(3006653) Thiamine [Moles/volume] in Blood
29
222
1.31
0.68
1.4
1.3
nmol/l
136.9
130.4
0.42
29
222
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
20
144
1.39
0.67
3.0
1.9
mg/l
7.8
9.7
0.82
14
113
(3036603) Volume of Urine
44
356
1.24
0.67
1.5
1.4
ml
1758.6
2015.7
—
7
81
(3023419) Bacteria identified in Sputum by Culture
65
548
1.19
0.67
2.8
2.5
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
48
393
1.22
0.66
2.6
2.2
u/field
1.5
2.3
0.85
24
161
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
90
781
1.15
0.66
1.3
1.3
u/l
24.6
31.5
1.64
76
637
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
21
154
1.36
0.64
1.3
1.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
100
876
1.14
0.64
1.4
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
31
242
1.28
0.64
1.5
1.4
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
5
29
1.72
0.64
1.0
1.1
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
5
29
1.72
0.64
1.0
1.0
—
—
—
0
0
(3006576) Bicarbonate [Moles/volume] in Blood
16
112
1.43
0.63
7.8
5.6
mmol/l
25.1
25.5
0.12
16
101
(3042733) HLA Ab [Presence] in Serum
16
112
1.43
0.63
4.2
5.0
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
100
879
1.14
0.62
1.4
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
86
748
1.15
0.62
1.7
1.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
35
279
1.26
0.62
1.9
2.7
e6/l
722.3
771.9
0.11
11
115
(3032743) Legionella sp IgG Ab [Presence] in Serum
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
5
30
1.67
0.61
1.0
1.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
30
235
1.28
0.61
1.9
1.6
—
—
—
0
0
(3016750) Collection duration of Urine
30
235
1.28
0.61
2.1
2.3
min
506.0
501.4
0.11
23
168
(3017354) Segmented neutrophils/100 leukocytes in Blood
50
416
1.20
0.60
2.3
3.2
%
58.8
57.6
0.16
38
278
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
44
362
1.22
0.60
1.4
1.3
nmol/l
1.4
1.5
0.14
38
325
(40768806) Pleura Pathology biopsy report
32
400
0.80
0.59
1.4
1.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
46
381
1.21
0.59
1.6
1.6
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
21
157
1.34
0.59
3.4
3.5
mg/l
10.4
7.5
1.12
14
127
(3033942) Copper [Moles/time] in 24 hour Urine
0
23
0.00
0.58
0.0
1.0
—
0.2
—
0
7
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
28
219
1.28
0.58
1.3
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
28
219
1.28
0.58
1.3
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
28
219
1.28
0.58
1.3
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
28
219
1.28
0.58
1.3
1.5
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
23
175
1.32
0.58
1.0
1.1
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
13
89
1.46
0.58
1.2
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
15
106
1.42
0.57
1.3
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
65
558
1.17
0.57
1.7
1.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
27
211
1.28
0.57
1.8
2.0
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
6
36
1.67
0.56
3.0
1.9
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
37
301
1.23
0.56
1.1
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
10
149
0.67
0.56
1.4
1.9
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
19
141
1.35
0.56
1.4
1.6
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
8
55
1.46
0.56
1.1
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
53
448
1.18
0.56
1.1
1.2
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
24
185
1.30
0.56
1.6
1.3
pmol/l
22.4
65.7
—
8
58
(3028433) Virus identified in Specimen by Culture
20
150
1.33
0.55
1.2
1.1
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
15
107
1.40
0.55
1.4
1.3
umol/l
18.6
17.3
0.55
15
95
(3045142) Bone marrow Pathology biopsy report
58
495
1.17
0.55
1.2
1.4
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
34
275
1.24
0.55
1.3
1.2
—
—
—
0
0
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
30
239
1.26
0.55
1.1
1.3
umol/l
3.5
4.4
1.03
30
223
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
18
133
1.35
0.55
1.2
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
88
995
0.88
0.54
1.4
1.5
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
9
60
1.50
0.54
2.6
3.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
37
303
1.22
0.54
1.1
1.0
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
108
968
1.12
0.52
1.1
1.1
u/ml
2.1
1.2
0.37
52
378
(3039000) Anion gap in Blood
112
1006
1.12
0.52
5.9
7.3
mmol/l
10.9
11.1
0.22
97
898
(3018572) Chloride [Moles/volume] in Blood
112
1007
1.11
0.52
5.9
7.3
mmol/l
104.7
105.2
0.51
98
899
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
74
648
1.14
0.51
1.6
1.2
u/l
18.0
34.3
2.38
62
564
(3042517) Benzodiazepines panel - Urine
6
40
1.50
0.51
1.2
2.3
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
6
40
1.50
0.51
1.2
1.0
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
42
351
1.20
0.51
1.4
2.2
mmol/l
6.6
6.8
0.20
29
235
(3014271) Vancomycin [Susceptibility]
29
233
1.25
0.50
3.4
2.7
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
6
41
1.46
0.50
1.0
1.1
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
35
288
1.22
0.50
1.0
1.0
u/ml
1.7
1.5
—
8
86
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
21
162
1.30
0.50
2.0
1.8
%
141.7
170.4
1.12
21
150
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
329
3107
1.06
0.49
3.0
2.8
ug/l
0.8
0.7
0.17
224
1899
(3008401) Mugwort IgE Ab [Units/volume] in Serum
93
831
1.12
0.49
1.1
1.1
u/ml
0.9
1.1
0.19
46
348
(3043238) Trisomy 21 risk [Likelihood] in Fetus
101
907
1.12
0.48
1.4
1.5
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
7
47
1.49
0.47
8.4
9.3
mmol/l
3.8
5.5
—
7
47
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
58
503
1.15
0.47
1.4
1.9
pmol/l
173.6
199.0
1.07
53
470
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
34
281
1.21
0.47
1.2
1.1
u/l
1.1
1.1
0.05
12
133
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
19
146
1.30
0.47
1.2
1.1
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
71
627
1.13
0.45
2.1
2.1
mg/l
25.7
24.9
0.04
22
160
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
17
129
1.32
0.45
1.4
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
20
156
1.28
0.45
1.9
1.9
—
—
—
0
0
(3004451) EKG impression Narrative
26
210
1.24
0.45
1.2
1.3
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
42
357
1.18
0.44
1.0
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
28
229
1.22
0.43
1.4
1.8
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
34
284
1.20
0.43
1.0
1.0
u/ml
3.1
0.7
—
10
68
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
27
220
1.23
0.43
1.0
1.1
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
11
78
1.41
0.43
1.0
1.3
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
39
331
1.18
0.42
1.1
1.1
—
—
—
0
0
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
5
32
1.56
0.42
4.6
7.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
79
708
1.12
0.41
1.8
1.5
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
10
70
1.43
0.41
1.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
10
70
1.43
0.41
1.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
10
70
1.43
0.41
1.0
1.0
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
13
96
1.35
0.41
1.6
2.0
umol/l
15.3
17.7
0.33
13
96
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
16
0.00
0.41
0.0
4.9
—
384.6
—
0
16
(3015665) Acarus siro IgE Ab [Units/volume] in Serum
0
16
0.00
0.41
0.0
1.0
—
0.1
—
0
6
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
8
59
1.36
0.41
1.6
1.5
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
72
643
1.12
0.40
1.7
1.4
—
—
—
0
0
(4015189)
16
123
1.30
0.40
2.9
2.6
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
8
60
1.33
0.40
1.0
1.1
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
52
455
1.14
0.40
1.2
1.2
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
8
61
1.31
0.39
1.8
3.6
umol/l
50.3
40.5
—
8
50
(3034092) Cytoplasmic Ig cells/100 cells in Blood
8
61
1.31
0.39
8.1
10.6
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
10
71
1.41
0.39
1.8
1.2
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.4
—
1.8
—
0
19
(3044007) Cell count panel - Peritoneal fluid
10
137
0.73
0.39
1.4
1.9
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
17
133
1.28
0.38
4.8
3.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
17
133
1.28
0.38
4.8
3.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
9
66
1.36
0.38
2.9
2.9
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
5
36
1.39
0.38
1.0
1.1
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
9
67
1.34
0.38
1.6
2.2
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
44
383
1.15
0.37
1.3
1.3
mmol/l
12.3
12.1
0.04
14
82
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
192
1807
1.06
0.36
3.9
3.3
u/ml
205.0
1715.5
1.51
160
1515
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
12
90
1.33
0.35
1.6
1.4
ng/l
106.6
100.1
0.07
12
90
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
27
227
1.19
0.34
1.5
2.1
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
6
44
1.36
0.34
3.7
2.6
mg/l
0.6
1.1
—
6
29
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
206
1948
1.06
0.34
1.3
1.5
—
—
—
0
0
(40768441) Liver Pathology biopsy report
45
396
1.14
0.33
1.4
1.3
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
24
201
1.19
0.32
6.5
4.4
u/ml
348.1
54.7
—
7
32
(3013166) Neutrophils/100 leukocytes in Synovial fluid
17
137
1.24
0.32
1.3
1.4
%
37.2
51.7
0.81
11
117
(3036782) Glucose [Moles/volume] in Pleural fluid
39
342
1.14
0.31
1.6
1.3
mmol/l
6.2
6.5
0.32
34
318
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
98
0.71
0.30
2.7
2.1
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
23
193
1.19
0.30
1.9
1.9
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
7
54
1.30
0.30
1.1
1.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
43
381
1.13
0.30
1.3
1.2
mg/l
37.5
38.1
0.03
36
323
(3008536) Aspergillus sp Ab [Presence] in Serum
10
75
1.33
0.30
1.6
1.8
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
11
84
1.31
0.30
1.4
1.2
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
7
55
1.27
0.30
1.3
1.1
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
7
56
1.25
0.29
15.4
7.5
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
8
108
0.74
0.29
1.1
1.2
—
—
—
0
0
(4027681)
33
288
1.15
0.29
1.3
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
78
847
0.92
0.28
1.6
1.7
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
12
151
0.79
0.28
1.6
1.6
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
38
337
1.13
0.27
1.8
1.6
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
21
247
0.85
0.27
1.7
1.2
u/l
9.5
10.7
0.27
21
222
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
30
262
1.15
0.26
1.0
1.1
u/l
25.6
22.5
0.15
21
194
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
41
367
1.12
0.25
1.1
1.1
mg/l
265.0
249.6
0.15
36
321
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
28
320
0.87
0.25
1.4
1.6
mmol/l
8.0
7.8
0.15
18
198
(3000285) Sodium [Moles/volume] in Blood
9
72
1.25
0.25
1.0
1.1
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
29
254
1.14
0.25
1.8
1.4
u/l
11.6
12.7
0.48
29
242
(3035880) pH of Pleural fluid
24
207
1.16
0.25
1.6
1.3
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
31
273
1.14
0.25
1.4
1.5
—
—
—
0
0
(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma
30
264
1.14
0.24
1.0
1.1
u/l
95.9
79.8
0.79
21
198
(3024869) Neuronal Ab [Presence] in Serum
11
87
1.26
0.24
1.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
49
538
0.91
0.24
2.0
1.7
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
22
189
1.16
0.24
8.1
4.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
40
360
1.11
0.23
1.1
1.2
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
84
785
1.07
0.23
1.1
1.1
u/ml
1.2
2.4
0.79
18
184
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
23
264
0.87
0.23
12.7
11.9
nmol/l
783.7
822.6
0.14
23
253
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
0
11
0.00
0.21
0.0
1.1
—
1.5
—
0
11
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
213
2051
1.04
0.21
1.5
1.5
—
—
—
0
0
(3034614) HLA Ag [Interpretation]
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.0
—
12097.4
—
0
5
(3019897) Erythrocyte distribution width [Ratio] by Automated count
69
644
1.07
0.20
2.8
2.8
%
13.2
13.2
0.15
69
635
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
19
164
1.16
0.20
1.9
2.9
umol/l
25.3
29.0
0.73
14
127
(3008757) Leukocyte morphology finding [Identifier] in Blood
51
470
1.09
0.20
2.6
3.7
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
48
1.25
0.20
1.0
1.1
—
—
—
0
0
(4281824)
79
742
1.07
0.20
1.1
1.2
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
6
50
1.20
0.19
2.3
2.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
157
1637
0.96
0.19
1.9
1.9
—
—
—
0
0
(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid
6
51
1.18
0.19
2.8
1.3
u/l
38.3
735.5
—
6
34
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
632
6201
1.02
0.19
4.8
4.4
%
31.9
33.1
2.20
442
4114
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
52
561
0.93
0.19
1.1
1.0
u/ml
0.2
0.3
0.47
14
125
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
21
184
1.14
0.19
1.0
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
10
81
1.23
0.18
1.1
1.5
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
53
1.13
0.18
1.0
1.0
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
38
347
1.10
0.18
1.6
1.5
u/l
6.3
5.9
0.06
17
168
(3017569) Oxygen content in Arterial blood
22
194
1.13
0.18
2.0
2.3
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
24
269
0.89
0.18
17.3
17.2
nmol/l
1435.5
1477.6
0.09
24
262
(44806071)
7
59
1.19
0.18
1.0
1.1
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
7
61
1.15
0.17
1.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
22
195
1.13
0.17
1.2
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
7
63
1.11
0.17
1.0
1.0
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
24
215
1.12
0.16
2.4
2.4
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
14
120
1.17
0.16
1.0
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
69
652
1.06
0.15
4.4
5.3
umol/l
333.5
374.0
1.33
59
568
(3047189) Immunofixation for 24 hour Urine
21
187
1.12
0.15
1.9
1.8
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
32
349
0.92
0.15
1.1
1.1
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
6
76
0.79
0.15
1.0
1.1
—
—
—
0
0
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
10
83
1.21
0.15
1.3
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
9
78
1.15
0.15
18.0
7.9
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
51
544
0.94
0.15
2.4
2.3
mmol/l
106.1
105.4
0.58
51
539
(3041354) Potassium [Moles/volume] in Venous blood
51
544
0.94
0.15
2.4
2.3
mmol/l
4.1
4.0
0.37
51
539
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
18
159
1.13
0.15
1.2
1.2
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
16
140
1.14
0.15
2.8
3.3
ng/l
53.7
150.2
—
10
55
(3051101) Glucose [Moles/volume] in Cord blood
9
81
1.11
0.15
3.2
6.7
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
7
86
0.81
0.14
1.6
1.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
169
1637
1.03
0.14
1.3
1.3
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
10
118
0.85
0.14
1.0
1.0
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
111
1069
1.04
0.13
1.4
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
287
2932
0.98
0.13
1.4
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
11
127
0.87
0.12
1.3
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
12
104
1.15
0.12
1.3
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
28
303
0.92
0.12
1.8
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
33
307
1.08
0.12
1.5
1.5
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
27
249
1.08
0.11
1.9
2.3
umol/l
14.4
24.1
—
5
20
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
27
292
0.92
0.11
1.3
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
111
1073
1.04
0.11
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
111
1073
1.04
0.11
1.4
1.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
79
758
1.04
0.11
1.4
1.5
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
19
172
1.10
0.11
1.3
1.6
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
19
172
1.10
0.11
1.3
1.6
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
111
1074
1.03
0.11
1.4
1.4
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
12
105
1.14
0.11
1.0
1.4
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
31
289
1.07
0.11
1.2
1.1
ratio
1.0
1.1
2.65
12
104
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
10
86
1.16
0.11
1.0
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
71
681
1.04
0.11
1.1
1.1
iu/ml
23.8
1104.0
0.73
14
159
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
10
115
0.87
0.10
1.0
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
51
536
0.95
0.10
2.4
2.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
104
1007
1.03
0.10
2.7
2.3
—
—
—
0
0
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
16
177
0.90
0.10
2.1
2.3
nmol/l
171.5
148.9
0.35
16
153
(3025549) Creatine [Moles/time] in 24 hour Urine
5
45
1.11
0.09
1.2
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
15
135
1.11
0.09
1.1
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
15
135
1.11
0.09
1.2
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
120
1167
1.03
0.09
1.4
1.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
23
248
0.93
0.09
1.2
1.3
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
19
174
1.09
0.09
1.4
1.7
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
5
48
1.04
0.09
1.6
2.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
42
399
1.05
0.09
1.6
1.4
e6/l
192618.0
55860.3
0.44
24
228
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
124
0.89
0.09
1.0
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
26
243
1.07
0.08
1.1
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
130
1332
0.98
0.08
1.3
1.4
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
6
57
1.05
0.08
1.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
12
107
1.12
0.08
3.3
3.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
5
62
0.81
0.08
1.2
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
7
66
1.06
0.08
1.1
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
42
401
1.05
0.08
2.5
2.9
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
24
255
0.94
0.07
1.0
1.0
u/ml
0.3
2.8
—
6
37
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
11
122
0.90
0.07
2.1
3.2
—
—
—
0
0
(4133840)
9
105
0.86
0.06
1.0
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
66
679
0.97
0.06
1.1
1.1
u/ml
4.0
3.6
0.08
24
256
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
13
119
1.09
0.06
1.0
1.0
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
29
304
0.95
0.05
1.0
1.0
ng/l
316.4
346.6
0.22
18
210
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
20
188
1.06
0.05
1.2
1.2
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
25
263
0.95
0.05
1.1
1.1
u/ml
6.6
6.4
—
7
41
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
28
267
1.05
0.05
1.1
1.1
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
70
686
1.02
0.04
1.2
1.3
mmol/l
7.2
7.3
0.22
49
500
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
19
200
0.95
0.03
2.8
3.4
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
29
301
0.96
0.03
1.3
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
21
200
1.05
0.03
9.3
11.6
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
64
628
1.02
0.03
1.1
1.1
u/ml
1.7
3.8
1.99
26
248
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
30
309
0.97
0.02
1.0
1.0
ng/l
44.2
45.7
0.05
17
207
(3012441) Differential panel - Pleural fluid
36
369
0.98
0.02
1.5
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
23
222
1.04
0.02
1.3
1.8
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
11
103
1.07
0.02
1.2
1.1
u/ml
52.0
49.2
0.10
11
98
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
33
322
1.02
0.01
1.0
1.1
nmol/l
14.6
11.5
—
5
65
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
30
306
0.98
0.00
1.0
1.0
ng/l
899.5
713.4
1.29
19
201
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
32
318
1.01
0.00
2.0
1.5
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
145
0.97
0.00
1.0
1.1
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
14
145
0.97
0.00
1.6
1.3
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
30
295
1.02
0.00
1.9
2.0
ug/l
6.1
3.9
0.59
24
267
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
11
106
1.04
0.00
1.2
1.2
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
14
144
0.97
0.00
1.5
1.9
e6/l
3004.1
26944.0
—
8
77
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
12
123
0.98
0.00
1.0
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
39
394
0.99
0.00
1.4
1.4
g/l
1.0
1.0
0.41
39
394
(3025577) Chromium [Mass/volume] in Blood
29
289
1.00
0.00
1.9
2.1
ug/l
2.8
2.9
0.02
24
251
(3045788) Cell count panel - Pleural fluid
35
351
1.00
0.00
1.8
1.4
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
43
429
1.00
0.00
3.6
2.8
mg/l
21.5
25.3
0.12
28
305
(3022670) pH of Venous cord blood
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count
0
9
0.00
0.00
0.0
4.7
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
5
52
0.96
0.00
1.2
1.1
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
6
62
0.97
0.00
1.2
1.4
—
—
—
0
0
(3012932) Hazelnut IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
21.2
—
0
6
(3032057) Clostridioides difficile [Presence] in Stool
9
91
0.99
0.00
1.2
1.9
—
—
—
0
0
(3040794) Aluminum [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004268) Protein electrophoresis panel - Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3020093) Fractional oxyhemoglobin in Venous cord blood
0
7
0.00
0.00
0.0
1.1
—
69.1
—
0
7
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
5.9
—
0.2
—
0
8
(3023199) Leukocytes [#/volume] in Pleural fluid
45
450
1.00
0.00
1.6
1.4
e6/l
1130.9
2233.2
2.09
35
321
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
1226.7
—
0
6
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
6
66
0.91
0.00
3.2
2.0
—
—
—
0
0
(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
7
79
0.89
0.00
6.3
5.8
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
9
89
1.01
0.00
18.0
7.7
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
6
0.00
0.00
0.0
6.8
—
73.8
—
0
6
(3008343) Lysozyme [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
0.5
—
0
5
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
40.6
—
0
5
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
7
79
0.89
0.00
3.1
2.9
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.1
—
1.1
—
0
7
(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
16.7
—
0
6

Mortality – FinRegistry

Association

Association between endpoint L12_ATROPHICSKIN and mortality.

Females

Parameter HR [95% CI] p-value
L12_ATROPHICSKIN 0.847 [0.77, 0.94] 0.001
Birth year 0.998 [0.99, 1.01] 0.531

During the follow-up period (1.1.1998 — 31.12.2019), 2303 out of 20189 females with L12_ATROPHICSKIN died.

Males

Parameter HR [95% CI] p-value
L12_ATROPHICSKIN 1.037 [0.89, 1.21] 0.637
Birth year 0.987 [0.98, 1.0] 0.005

During the follow-up period (1.1.1998 — 31.12.2019), 484 out of 5939 males with L12_ATROPHICSKIN died.

Mortality risk

Mortality risk for people of age

years, who have L12_ATROPHICSKIN.

N-year risk Females Males
1 0.076% 0.214%
5 0.52% 1.158%
10 1.255% 2.885%
15 2.491% 5.356%
20 4.366% 9.182%

Relationships between endpoints

Index endpoint: L12_ATROPHICSKIN – Atrophic disorders of skin

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data